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1 Zusammenfassung 
Parasitische Würmer gehören mit über 3,5 Milliarden Betroffenen zu den weltweit verbreite-
testen Infektionskrankheiten. Der Erfolg dieser Parasiten beruht auf ihren ausgefeilten Me-
chanismen mit denen sie das Immunsystem ihrer Wirte manipulieren. Interessanter Weise 
gehen Wurminfektionen mit einer geringeren Wahrscheinlichkeit an Allergien zu erkranken 
einher. Parasiten manipulieren ihre Wirte u. a. durch die Sekretion verschiedener 
immunmodulatorischer Moleküle. Wie genau diese Moleküle wirken und welche Mechanis-
men evtl. noch eine Rolle spielen ist weitgehend unbekannt.  
Diese Arbeit verfolgte zwei Ziele. Zum einen sollte RNA interference (RNAi), eine Methode 
zur genetischen Manipulation, anhand des Modellmoleküls Tropomyosin etabliert werden. 
Zum anderen wurden die Auswirkungen von rekombinantem Tropomyosin der Filarie Acan-
thocheilonema viteae (rAv-TMY) auf die Entstehung entzündlicher Atemwegserkrankungen 
im Mausmodell untersucht.  
RNAi basiert auf dem Einbringen doppelsträngiger RNA in den Zielorganismus, was zum Ab-
bau der homologen mRNA und damit zu einem „knock down“ des Zielgens führt. RNAi wird 
in unterschiedlichen Organismen wie z.B. dem freilebenden Nematoden Caenorhabditis ele-
gans eingesetzt. In dieser Arbeit konnte am Beispiel des essentiellen Muskelproteins Tropo-
myosin gezeigt werden, dass der Strongylide Heligmosomoides polygyrus bakeri im Gegen-
satz zu C. elegans unempfänglich für RNAi ist. Dies war unabhängig davon ob eine invasive 
Transfektionsmethode zur Einbringung von dsRNA wie Elektroporation oder eine nicht inva-
sive wie „Feeding“ oder „Soaking“ genutzt wurde. Eine Analyse verschiedener EST-
Datenbanken ergab das Strongyliden und anderen parasitischen Nematoden verschiedene 
Gene der RNAi-Maschinerie fehlen. Unter anderem auch die sog. SID Gene, die in C. elegans 
für die exogene Aufnahme und den internen Zell zu Zell Transport von dsRNA verantwortlich 
sind.  
Desweiteren wurde das rekombinante Muskelprotein rAv-TMY in einem OVA induziertem 
Asthmamodell eingesetzt. Tropomyosin ist u.a. als Lebensmittelallergen aus Schalentieren 
bekannt, scheint aber, trotz seiner IgE induzierenden Wirkung, keine allergischen Reaktionen 
in Wurminfektionen hervorzurufen. Tiere wurden während der Sensibilisierungsphase mit 
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rAv-TMY behandelt, so dass das Molekül bereits während der Initiation der Immunreaktion 
wirken konnte. Eine viermalige Behandlung mit rAv-TMY in einem Zeitraum von vier Wochen 
führte zu verringerten entzündlichen Reaktionen in den Atemwegen. Die Analyse immunolo-
gischer Parameter ergab, dass rAv-TMY signifikant den Einstrom von Entzündungszellen in 
die Atemwege, allen voran Eosinophile, reduziert. Dies lässt sich durch die verringerte Aus-
schüttung an IL-5, Eotaxin und MCP-5 zurückführen. Zudem wurde die Bildung von antigen-
spezifischen IgE verringert während sich die Produktion blockierender IgG1 Antikörper er-
höhte.  
Zusammenfassend belegen die vorliegenden Daten, dass sich RNAi als Manipulationsmetho-
de für Nematoden nicht oder nur in geringem Maße eignet. 
Weiterhin konnte mit dieser Arbeit gezeigt werden, dass rAv-TMY anti-allergische Eigenschaf-
ten hat. Dieser Umstand ist umso interessanter, als Tropomyosin aus Schalentieren als Aller-
gen bekannt ist. Somit scheinen es Würmer geschafft zu haben ihre „Allergene“ so zu modifi-
zieren, das diese trotz ihrer teilweise allergenen Eigenschaften (IgE, IL-4) kaum, oder sogar 
antiallergisch wirken. Damit stellt rAv-TMY ein interessantes Kandidatenmolekül zur Behand-
lung allergischer Reaktionen dar. Desweiteren kann der Vergleich von allergenem, nicht aller-
genem und modulatorischem Tropomyosin wichtige Informationen über die allgemeinen 
Eigenschaften von Allergenen und ihrer molekularen Struktur geben. 
Parasiten, Nematoden, parasitische Nematoden, Filarien, Hakenwürmer, Heligmoso-
moides polygyrus, Acanthocheilonema viteae, Asthma, Allergie, RNAi, Tropomyosin, 
Immunmodulation 
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1 Summary 
Parasitic worms are among the world's most prevalent infectious diseases with more than 
3.5 billion. The success of these parasites is based on their sophisticated ways to manipulate 
the immune system of their hosts. Interestingly, worm infections abate the risk to develop 
allergic disorders. Parasites manipulate their hosts amongst others by the secretion of vari-
ous immunomodulatory molecules. How exactly these molecules operate and what mecha-
nisms may play a role is so far largely unknown.  
This work had two goals. First, to establish RNA interference (RNAi), a method of genetic 
manipulation, using tropomyosin as target gene. Second, to examine the effects of recombi-
nant tropomyosin of the filariae Acanthocheilonema vitae (rAv-TMY) on the formation of an 
inflammatory airway disease in mice.  
RNAi is based on the introduction of double-stranded RNA into a target organism, leading to 
the degradation of homologous mRNA and thus resulting in a "knock down" of the target 
gene. RNAi is used in various organisms such as the free-living nematode Caenorhabditis ele-
gans. Using tropomyosin as example, this study demonstrates that the strongylid Heligmo-
somoides polygyrus bakeri, in contrast to C. elegans, is insensitive to RNAi. This was regard-
less of whether an invasive transfection method was used, such as electroporation or a non-
invasive, such as "Feeding" or "soaking". An analysis of various EST databases reveled that 
strongylids and other parasitic nematodes lack different genes of the RNAi machinery. 
Among others, the so-called SID genes, which are responsible for uptake and spreading of 
dsRNA in C. elegans.  
Furthermore, the recombinant muscle protein rAv-TMY was applied in an OVA-induced 
asthma model. Tropomyosin is a known food allergen of shellfish but despite inducing an IgE 
response helminth tropomyosin seems not to cause allergic responses during infections. 
Animals were treated during the sensitization phase but prior to airway provocation with 
rAv-TMY, so that the molecule could interfere with the initiation of the immune response. A 
four-time treatment with rAv-TMY over a period of four weeks resulted in decreased inflam-
matory responses in the airways. The analysis of immunological parameters showed that rAv-
TMY significantly reduces the influx of inflammatory cells into the airways, especially eosino-
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phils. This can be explained by the decreased secretion of IL-5, eotaxin and MCP-5. In addi-
tion, the formation of antigen-specific IgE was impaired whereas the production of the block-
ing antibody IgG1 was increased.  
In summary, the present data show that RNAi is not or only to a small extent useful as 
method to genetically manipulate nematodes.  
Furthermore, this work demonstrates the anti-allergic properties of rAv-TMY. This fact be-
comes even more intriguing when considering that tropomyosin is a known allergen of shell-
fish. Thus, helminths seem to have modified their "allergens" in such a way that they do not 
exacerbate allergy, but in fact can even abrogate allergic responses. For this reason rAv-TMY 
becomes an interesting model molecule for the treatment of allergic diseases. Furthermore, 
the comparison of allergenic, non-allergenic and modulatory tropomyosin might put some 
light on the nature of allergens and their molecular patterns. 
Parasites, nematodes, parasitic nematodes, filariae, hookworms, Heligmosomoides po-
lygyrus, Acanthocheilonema viteae, asthma, allergy, RNAi, tropomyosin, immunomodu-
lation 
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2 Introduction 
2.1 General issues 
2.1.1 Parasitic nematodes 
Nematode infections are one of the most widespread infectious diseases with over 3.5 billion 
infected people worldwide [1,2]. The evolutionary success of these parasites is based on their 
sophisticated ability to regulate the host immune system. The modulation of the immune 
response was acquired during the long lasting “evolutionary arms race” between parasite 
and host. Since this is a reciprocal process the host immune system became adapted to the 
parasites, an evolutionary process which becomes obvious when the worms are eliminated. 
The evaluation of anti-helminth treatments revealed an increased risk to develop allergic 
disorders upon clearance of the worm infection [1]. This phenomenon is also seen in west-
ernized countries were improved sanitation and hygiene standards go along with increased 
prevalence for allergic disorders. Understanding the modulatory mechanisms might enable 
us to utilize the modulatory function of helminth derived molecules.  
This study investigates the use of RNAi as a method of reverse genetics in parasitic nema-
todes. For this purposes an intestinal hookworm of rodents, Heligmosomoides polygyrus 
bakeri bakeri, was used. H. p. bakeri is kept in BALB/c mice, easy to maintain under labora-
tory conditions and has a simple life cycle (Fig. 1a). H. p. bakeri belongs to the genus 
strongylida and is widely used as a model for human hookworm infections. 
In the second part the ability of Acanthocheilonema viteae derived tropomyosin to interfere 
with allergic reaction was studied. A. viteae is a parasite of gerbils that dwells in the subcuta-
neous tissues. It belongs to the Filarioidea and is used as a model organism for filarial dis-
eases in man such as onchocerciasis. Details of the life cycles can be found in Fig. 1b.  
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Fig. 1 a) Life cycle of H. p. bakeri. Mice are infected by oral uptake of infectious larvae (L3) which invade the 
gastric and duodenal submucosa within hours. Cyst formation occurs during the histotrophic phase of larval 
development from L3 to L4 stage. The L4 reenters the gut lumen and develops to adult worms which start to 
release eggs by day 10 p.i. Hatching of eggs and development to the L3 stage takes place within the feces. L3 
actively migrate away from the feces to be ingested. Modified from Rausch S., 2008; L: larvae b) Life cycle of A. 
viteae. A. viteae is a tissue dwelling filariae of rodents. The host becomes infected during the blood meal of the 
arthropod host (tick - Ornithodoros moubata). After a migration phase, the developing L4 settles in the connec-
tive or subcutaneous tissues. The development to adults is completed 6 weeks p.i. and the females start to 
release microfilariae (mf) which circulate in the blood stream and are taken up by ticks during the blood meal. 
Mf leave the tick stomach and migrate to the thoracic muscles where they develop to L3 within the sarcoplas-
ma. Developed L3 immigrate into the salivary glands and wait for the next blood meal. L: larvae, mf: microfila-
riae 
 
2.1.2 Tropomyosin 
Parasitic nematodes constantly excrete or secrete potent allergens or release them when 
dying. Among these is tropomyosin a muscle protein abundant in most species.  
Tropomyosin is present in all eukaryotic cells and found in multiple isoforms depending on 
the type of tissue [1]. It is expressed as long filaments that form dimmers of ~20 Å in diame-
ter and ~400 Å in length in a coiled-coil manner [2]. The coiled-coil structure results from 
heptad repeats (abcdefg) where ‘a’ and ‘d’ are hydrophobic amino acid residues and the 
other positions represent polar or ionic amino acids. The ‘a’ and ‘d’ positions interact with 
the same positions of the other chain stabilizing the coiled-coil structure. The residues ‘b’, ‘c’ 
and ‘f’ are located in the outer part and can interact with other proteins such as actin. The N- 
and C-termini of each filament have overlapping residues that lead to a head-to-tail associa-
tion [1]. These repeated filaments are associated with actin chains where they regulate my-
osin binding together with the troponin complex in a Ca2+ dependent reaction [3]. Therefore 
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tropomyosin is essential for the proper function of the movement apparatus but also be-
lieved to be involved in the intracellular transportation system of non-muscle cells [4]. 
Interestingly tropomyosin is the major food allergen of shellfish and considered a pan aller-
gen due to its wide distribution. Shellfish tropomyosin has several B-cell epitopes that fea-
ture high cross-reactivity with invertebrate tropomyosins of different species (Fig. 2). Map-
ping the IgE epitopes for shrimp tropomyosin showed that the epitopes cluster in five regions 
of the protein that correspond to the binding regions of the two tropomyosin helices. These 
regions are in contrast to the actin binding regions less conserved between invertebrate and 
vertebrate tropomyosin providing an explanation for the different immunogenicity [5]. How-
ever, invertebrate tropomyosin does not only induce B-cells but has also the ability to induce 
a strong T-cell response [6]. The induced antibody responses are highly cross-reactive be-
tween invertebrate species [7]. The fact that parasitic worms constantly confront their hosts 
with large numbers and amounts of antigens would suggest a strong allergic response to 
these antigens and cross-reactivity to the respective antigens of other species. This becomes 
even more evident if one considers the example of patients infected with the filarieae On-
chocerca volvulus that can harbor up to 12 million microfilariae which are subjected to con-
stant turnover. Furthermore, tropomyosin was found to be expressed not only in the muscle 
layers but also in the cuticle of O. volvulus and Trichinella spiralis exposing the antigen di-
rectly to the immune system [8,9]. In regard to natural worm infections it seems, however, 
that the parasites induce no or only mild allergic reactions. The question of clinically relevant 
cross-reactivity between invertebrate tropomyosins has been addressed only in a few studies 
of which non dealt with parasitic tropomyosin [10,11,12]. In contrast, vertebrate tropomy-
osin has been reported to be non-allergenic in humans [13] probably due to the high homol-
ogy among vertebrate tropomyosins.  
A. viteae tropomyosin (Av-TMY) used in this study was characterized as an important antigen 
in vaccination studies. Animals immunized with irradiated L3 become resistant to challenge 
infection. Sera of these mice strongly react with a 41 kDa band in a Western Blot using whole 
worm extract [14]. Intriguingly, using Av-TMY in a receptor study revealed TLR-2 dependent 
signaling. HEC cells transfected with a TLR-2 luciferase reporter plasmid produced a strong 
signal upon stimulation with rAv-TMY that was not seen using a TLR-4 reporter construct. 
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Similar, RAW cells (a macrophage cell line) started to expression of IL-4 and IL-10 in response 
to rAv-TMY. The expression of IL-4 and IL-10 was abrogated when macrophages were treated 
with anti-TLR-2 mAb but not when an anti-TLR-4 mAb was used. Furthermore, macrophages 
isolated ex vivo from MyD88 knockout mice showed an impaired IL-10 expression upon Av-
TMY stimulation indicating Av-TMY signaling is MyD88 dependent (Eckert J., unpublished 
data). The fact that filarial tropomyosin protects mice against challenge infections [15] but at 
the same time is able to induce a regulatory cytokine seems to be a conflicting capacity. On 
the other hand a modulatory function of this molecule might explain why tropomyosin of 
filariae seems not to induce drastic allergic reactions in a natural infection. The above men-
tioned findings lead to the speculation that Av-TMY might be less allergenic at least in regard 
to cross reactivity and might possess modulatory capacities that can have spillover effects on 
allergic reactions induced by unrelated allergens. 
 
Fig. 2 Structure and epitopes of tropomyosin. a) Tropomyosin consists of two 400 Å α-helices that show a se-
quence of seven repeating amino acids where the positions ‘a’ and ‘d’ are hydrophobic amino acid residues and 
the remaining positions are taken by polar or ionic amino acids. The ‘a‘ and ‘d‘ positions of each chain interact 
with each other resulting in a coiled-coil filament that is stabilized by the interaction of ‘e‘ and ‘g‘. The positions 
‘c’, ‘b’ and ‘f’ are located in the outer part of the filament enabling them to interact with actin. The N- and C-
terminus have overlapping residues which create long filaments by a head-to-tail overlap (modified from Ste-
wart, 2001 and Perry, 2001).  b) Tropomyosin filaments run along actin filaments where they are complexed 
with Troponin. After Ca2+ influx, this complex is shifted by 35° and enables myosin to bind to actin for move-
ment (modified from Gordon, 2000). c) Schematic representation of actin binding sites A1-A7 of mammalian 
tropomyosins and the IgE binding regions of P. aztecus Tropomyosin described by Ayuso, 2002. The IgE regions 
show partial overlap with the actin binding sites, indicating that actin binding sites are not excluded from being 
immunogenic. (extracted from Perry, 2001 and Sereda, 2008) 
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2.2 Part I – RNA interference in Heligmosomoides polygyrus bakeri 
2.2.1 Genetic manipulation of parasitic nematodes 
To date genetic manipulation of parasitic nematodes has proven largely unsuccessful. The 
various reasons include the complex lifecycles, poor accessibility and the small amount of 
genome information available. The technique of RNA interference (RNAi) gave rise for hope 
to have a method that prevents the need to (stably) integrate the gene of interest into the 
genome and thereby knock down genes in parasitic nematodes. To establish RNAi, H. p. bak-
eri, a well-established murine model for intestinal nematode infections was used. H. p. bakeri 
exhibits the characteristic features of a nematode infection [16,17], is easy to maintain in the 
laboratory and therefore suitable to study RNA interference (RNAi). RNAi is a highly con-
served mechanism whose function is to protect the cells from double-stranded RNA (dsRNA) 
derived from virus infections or to regulate transposable elements and gene transcription 
[18,19]. RNAi operates via degradation of messenger RNA (mRNA) that shows homology to 
the dsRNA (see Fig. 3). RNAi was first described in the free-living nematode Caenorhabditis 
elegans [20] but is in the meantime established for a range of organisms including plants 
[21], insects [22] and vertebrates [23,24]. However, only nematodes and planarians 
[25,26,27,28] as well as plants [29] develop systemic RNAi. In C. elegans it was shown that 
RNAi is dependent on several proteins that enable uptake, spreading and processing of 
dsRNA [28,30,31,32,33]. Furthermore, it was shown that RNAi is heritable for more than 
three generations in C. elegans [20,34]. Although RNAi is a conserved mechanism, the way of 
dsRNA uptake differs between organisms. In C. elegans the systemically expressed proteins 
SID-1 and SID-2 facilitate the passive uptake of dsRNA as well as the systemic spread within 
the worm, whereby long sequences of dsRNA are favored (>100bp) and DNA is completely 
discriminated. Structure, kinetic and ATP independency makes it likely that SID-1 forms 
channels in the membrane for dsRNA diffusion [28,31]. SID-2 is mainly located in the intes-
tine and is only involved in the uptake of exogenous dsRNA into the cells [35]. This uptake 
machinery makes C. elegans susceptible to a variety of application methods like soaking and 
feeding.  
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Fig. 3 Principles and function of RNAi. RNAi was first discovered in C. elegans. This free-living nematode pos-
sesses trans-membrane proteins (SID-1/SID-2) that allow an ATP independent uptake of dsRNA into the cells. In 
experimental settings this can be utilized to deliver dsRNA by simply feeding dsRNA expressing bacteria to the 
worms or by soaking them in dsRNA containing medium. Alternatively dsRNA can be introduced by electropora-
tion. The natural function of RNAi is to protect the cell from double-stranded RNA viruses or for post-
transcriptional gene silencing (PSTG). The artificially introduced or cell produced dsRNA is recognized by DICER, 
an enzyme that cleaves the dsRNA strand into ~21 bp small interfering RNAs (siRNA). A single strand of siRNA is 
than incorporated into the RNA induced silencing complex (RISC) that degrades homologues mRNA and thereby 
silencing the respective gene. dsRNA: double stranded RNA, SID: systemic RNAi defici ent, siRNA: small interfer-
ing RNA, RISC: RNA induced silencing complex 
Soaking is an easily applicable method by which the worm is simply soaked in dsRNA contain-
ing media. In C. elegans soaking was used for high-throughput analyses and also the first 
RNAi experiments with parasitic helminths used soaking [36,37,38,39,40]. 
Feeding is based on dsRNA-producing bacteria fed to C. elegans. The dsRNA is delivered via 
the intestinal epithelium of the worm. Meanwhile feeding is the standard method in C. ele-
gans for functional genome screenings [41]. Additionally, feeding of dsRNA has also been 
used to manipulate parasitic nematodes such as the gastrointestinal nematode Trichos-
trongylus colubriformis [37] or planarians such as Schmidtea mediterranea [25]. 
The third method used in helminths, electroporation, is based on the formation of small 
pores within the cell membrane upon an electric pulse [37,42,43,44]. For this method 21 bp 
long small interfering RNAs are designed and used to transfect the organism.  
  
Introduction 15 
In this work all three delivery methods were used to transfect different life stages of H. p. 
bakeri. 
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2.3 Part II – Influence of rAv-TMY on a murine model of allergic airway 
inflammation 
2.3.1 Immune modulation and evasion by helminths 
By definition parasitism is a close relationship in which one organism, the parasite, live at the 
expense of the host. Endoparasitic worms live within their respective host and are therefore 
directly exposed to the host immune system for a long period. Hosts have a variety of 
mechanisms to expel parasites, which in turn have developed intriguing ways to circumvent 
this leading to a well-balanced host-parasite equilibrium.  
The interaction between the host immune system and the worm might start when a larvae 
enters the host or hatches from an egg. The invader is immediately recognized as foreign by 
epithelial cells, innate immune cells and antigen presenting cells (APC) through their released 
or membrane bound antigens. The antigens are taken up by the APCs, such as dendritic cells 
(DC), macrophages (M∅), B-cells, processed and presented to CD4+ cells via MHC class II 
upon migration to the draining lymph nodes and the spleen. Extracellular pathogens usually 
favor the development of a Th2 response that leads to the production of the typical Th2 cy-
tokines IL-4, IL-5, IL-9 and IL-13. In this environment B-cells start to produce high amounts of 
antibodies that can opsonize the parasite thereby attracting eosinophils, basophils and 
macrophages to attack the parasite. The recruitment of cells is in addition supported by mast 
cells that release histamines, prostaglandins and chemokines upon FcεR bound IgE cross-
linking. The recruitment of further immune cells leads to a strongly Th2 biased environment 
around the parasite. Subsequently the parasite can either be directly killed or encapsulated 
or intestinal worms can be expelled by mucus hyper production and muscle hyper contractil-
ity induced by IL-13 and IL-9 [45]. 
However, some worms can live up to 15 years in their respective hosts despite being con-
fronted to the immune system [46]. Parasites have evolved different strategies to evade the 
constant attack of the host immune system. The evasion strategies include the shedding of 
opsonising antibodies either mechanically through movement/molting or chemically by pro-
teases preventing cell based killing. Some worms also escape inflammation by constantly 
moving or hiding in nodules. But the probably most elaborate survival strategy is an active 
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interference with and modulation of the host immune system. This not only prolongs para-
site survival but also prevents immune reactions detrimental for the host. Surprisingly 
helminths are known to skew the host immune system towards Th2 which seems to be con-
tradictory with the long survival of these parasites. On the other hand helminth infections 
are often found to induce regulatory T cells [47] and are associated with elevated levels of 
the regulatory cytokine IL-10 [48,49]. They are also accompanied by increased IgG4 antibody 
titers in humans a subclass that is unable to activate complement and less efficient in opson-
ising parasites to phagocytic cells. The modulation of the preferentially induced Th2 immune 
response is presumably achieved by the release of modulating molecules. A few have been 
isolated and characterized. One example are the homologues of human cystatin family re-
leased by different nematodes [50,51]. The cystein proteinase inhibitor Bm-CPI-2 released by 
Brugia malayi targets cathepsin B, L, S and a endopeptidase within the MHC class II pathway 
thereby inhibiting the antigen presentation [52]. Bm-CPI-2 shows homologies to human cys-
tatin C which is expressed at high levels in immature DCs and down regulated during matura-
tion [53]. Nematode cystatin could therefore keep dendritic cells in an immature status lead-
ing to T cell anergy [54]. Av17, a cystatin released by A. viteae, operates in a similar way. In 
addition Av17 triggers macrophages to produce the regulatory cytokine IL-10. IL-10 abates 
the expression of MHC class II and CD80/CD86 on DCs and subsequently the antigen presen-
tation [55]. IL-10 also skews the IgE/IgG4 ratio towards the blocking IgG4 subclass [56]. 
Modulation and communication of cells is strongly dependent on mediators such as cyto-
kines and chemokines. It comes as no surprise that parasites also utilize these pathways for 
their purposes. The best investigated examples are the TGF-ß homologue (TGH) of B. malayi 
[57,58] and the macrophage-migration inhibition factor (MIF) produced by various parasitic 
nematodes [59,60]. Bm-TGH2 binds to mammalian TGF-ß receptors and can thereby modu-
late the immune response similar to TGF-ß. Mammalian MIF is a pro-inflammatory cytokine 
that induces TNF-α expression in macrophages. The B. malayi released MIF acts in the same 
way on human monocytes in vitro what is somehow contradictory to the anti-inflammatory 
aim of the parasite. However, the authors claim that under in vivo conditions the permanent 
release of Bm-MIF could lead to an anti-inflammatory response [59]. Besides these “in-
tended” immune modulators helminths release a whole assortment of “unintended” anti-
gens. This especially holds true for filarial nematodes which produce high numbers of micro-
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filaria (Mf) circulating in the bloodstream or migrating in the tissue. Upon death or killing by 
macrophages the antigens are released rising the risk of an unregulated immune response. 
Interestingly parasites appear to have shaped their most immunogenic antigens to be less 
immunogenic or even to be modulatory. One example is tropomyosin (TM). The immuno-
genicity of TM seems to be dampened in filarial infections where filarial TM is released in 
high amounts but without inducing strong allergic responses nor enforcing the response to 
TM of different species. 
2.3.2 Asthma 
Allergic disorders such as asthma, atopic dermatitis and hay fever are on the rise in western 
countries. The hallmark of allergic disorders is an inappropriate immune response to other-
wise harmless antigens. With regard to asthma about 40% of the western population is 
atopic but only 7% develop asthma [61]. Atopic individuals show a remarkable IgE response 
to common environmental antigens whereas asthmatic individuals in addition develop a se-
vere inflammation followed by structural changes of the airways.  
2.3.2.1 Immunological reactions leading to airway hyper-reactivity 
The onset of asthma is a highly complex mechanism that can be divided into three phases: 
induction, early asthmatic reaction (EAR) and late asthmatic reaction (LAR). 
A fundamental process in the establishment of asthma is the sensitization to an allergen 
when it is first inhaled. The antigen is taken up by intraepithelial dendritic cells, a process 
enhanced by allergen specific surface bound IgE. The engulfed antigen is processed leading 
to its presentation on MHC class II molecules, expression of co-stimulatory molecules (CD80, 
CD86) and the migration of DCs to the mediastinal lymph nodes. Sensitization of T-cells oc-
curs only in contact with mature antigen presenting DCs expressing CD80/CD86 otherwise 
leading to T-cell anergy [61]. The decision if DCs mature depends on the co-stimuli during 
antigen uptake. It has been shown that immunogenic antigens often bear either an enzy-
matic activity or contaminated with LPS stimulating epithelial cells via protease activated 
receptors (PAR) or Toll-like receptors (TLR) to produce a variety of mediators like TSLP, IL-6, 
GM-CSF and CCL17. This not only attracts lymphocytes but also provides a maturation signal 
for DCs. After priming naïve CD4+ cells to become Th2 T-cells DCs migrate back to the airways 
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to become potent producers of mainly Th2 cytokines [54]. The following cascade leads to a 
massive influx and activation of different cell types. 
Among them mast cells to some extent play a role in linking innate and adaptive immunity by 
creating certain cytokine environment and by presenting antigens. As cells of the first line 
defense mast cells produce a myriad of different molecules which are released upon an ap-
propriate stimulus. Cross linking of IgE bound to the high affinity receptor Fcε leads to de-
granulation [61]. The preformed granules contain effector molecule like histamine, proteases, 
prostaglandins and cytokines. Together they increase smooth muscle contractility, microvas-
cular and tissue permeability and are also thought to contribute to airway remodeling [62]. 
Among the secreted cytokines are IL-4 and IL-5 leading to eosinophil maturation and re-
cruitment. Mast cells are recruited by stem-cell factor (SCF) released by epithelial cells that 
binds to the KIT receptor on the surface [62]. Attracted mast cells localize in the airway con-
nective-tissue, mucosa and in association with smooth muscle cells [61,63,64]. In the LAR 
mast cells are highly sensitized with IgE due to the massive upregulation of the FcεR. At that 
stage of the disease they are the main link between IgE and airway hyperreactivity (AHR).  
Eosinophils are thought to be the main effector cell type in the airways and also found in 
sputum and bronchoalveolar lavage fluid. Eosinophils derivate from CD34+ bone marrow 
precursors under the influence of IL-3, IL-5, GM-CSF and eotaxin 1-3 [65]. Upon activation 
with IL-5 they start to maturate and express several receptors such as CCR3, CCR5, L-selectin, 
ß2 integrin [66]. These receptors are used to attract eosinophils along a gradient of different 
chemoattractans (PGD2, CCL5, CCL7, CCL11, CCL24, RANTES) to and within the airways. 
Reaching their destination eosinophils become activated by stimuli such as secretory IgA, 
IgG, IL-5, GM-CSF and IL-3 [67]. Next they release cytotoxic molecules (MBP, ECP), lipid me-
diators (PGE2, leucotrienes), growth factors (TGF-ß, VEGF) and cytokines (IL-1, IL-2, IL-6, IL-4, 
IL-5, IL-13, TNF-α) [65] after cross linking of FcεRI/FcαRI or stimulation of the complement 
receptors [67,68]. 
Macrophages play an important role in induction and maintenance of asthma. As effector 
cells they are a source of reactive oxygen products, lysosomal enzymes and leukotrienes. As 
conductors they help to orchestrate the ongoing inflammation by attracting neutrophils, 
monocytes and T-cells but also limiting the cytokine response by releasing proteases such as 
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MMP9 and regulatory cytokines like IL-10 and TGF-β [61,64,69]. However, the precise role of 
macrophages in asthma is largely unknown [61]. 
Finally B cells are a relevant source of antigen-specific IgE under Th2 conditions which con-
tributes to airway inflammation. B cells primed by mucosa derived DCs turn into IgA secret-
ing plasma cells that migrate to the submucosa releasing high amounts of sIgA that can acti-
vate eosinophils. Under regulatory conditions B cells can also produce the blocking antibody 
IgG4 that counteracts the effects of IgE [70]. In addition B cells also serve as antigen present-
ing cells and some subsets can have regulatory functions by producing IL-10 [71]. 
In summary the induction of asthma is coupled to many different cell types and mediators 
which are precisely regulated. The Factors such as genetic background, nutrition and hygiene 
influencing this network are hardly understood. 
2.3.3 Worms and allergy 
The observation that a westernized lifestyle goes along with an increase of allergic disorders 
led to the formulation of the hygiene hypotheses by Strachan [72]. He postulated that a re-
duced exposure to Th1 driving infections during childhood as a result of improved sanitation 
and vaccination shifts the immune response to a Th2 response. This again escalates the risk 
to develop allergic disorders. The hygiene hypotheses has been refined and extended over 
the last 20 years mainly by including parasitic infections. To narrow down the factors influ-
encing the hygiene hypotheses such as bacterial and viral stimuli turned out to be difficult. 
This is of no surprise as allergies are usually multi-factorial diseases depending on several 
factors like the genetic background, environmental pollution, nutrition and site of inflamma-
tion. However, one trait that turned out to be quite consistent is the inverse correlation of 
helminth infections and the prevalence for allergic disorders although exceptions occur here 
as well. On the first glance it seems to be paradox that Th2 skewing infections should protect 
from Th2 based allergies. A lot of research has been invested resulting in the hypothesis of 
counter-regulation. It is hypothesized that the affords of the parasite to dampen the immune 
response against itself has bystander effects dampening the reaction to an allergen as well 
(see Fig. 4) [73,74,75,76]. IL-10 plays a central role in this hypothesis as a regulatory cytokine. 
IL-10 is produced by a wide variety of cells such as monocytes, macrophages, dendritic cells, 
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B cells, T cells and NKT cells following many different stimuli including stimulation by bacteria 
and parasites [73]. Interestingly, there is evidence that asthmatic patients have general low-
ered IL-10 expression [77,78,79] and therefore might tend to establish polarized immune 
reactions. Helminths have evolved sophisticated mechanisms to use the homeostatic fea-
tures of IL-10 to counterbalance the Th2 bias induced by their antigens [53].  
There are accumulating reports on the positive influence of helminths on the course of aller-
gic disorders. They include reports on the negative correlation between helminth infections 
and allergies [80,81,82,83,84,85,86,87,88,89], studies linking the effect of anti-helminth 
treatment with worsening of allergies [90,91] and studies on the underlying immunological 
parameters [92,93]. Nevertheless there are also reports on detrimental effects of worm in-
fections on allergic reactions [90,94,95,96]. It was also shown that helminth infections can 
have a different impact on different kinds of allergic disorders. For hookworm infections it 
was found that they can improve asthma but exacerbate dermatitis [97]. This was confirmed 
by meta-analysis of recent publications showing that Ascaris infections are likely to increase 
incidence of asthma whereas hookworms reduce incidence indicating that species and local-
ization of the parasite might also be important factors [98]. The above mentioned studies 
clearly show the ability of helminths to suppress allergic responses as consequence of re-
leased molecules that are able to mediate this modulation. A few immune modulators of 
helminths have been isolated and tested in a murine system for their suppressive capacities. 
Probably the best characterized molecule is ES-62 of the rodent filarieae A. viteae. ES-62 
forms complexes with Toll-like receptor 4 (TLR-4) and thereby inhibits the FcεRI-induced de-
granulation of human mast-cells. It protects mice from arthritis and mast-cell hypersensitivity 
in the lung and skin [99,100,101]. A second molecule derived from A. viteae is the cystatin 
Av17. Av17 is able to suppress inflammatory responses both in a Th2 model of asthma and a 
Th1 colitis model. The effects are dependent on macrophages and IL-10 [102]. Another 
helminth molecule is PAS-1 of the roundworm Ascaris suum. PAS-1 can reduce the airway 
hyperreactivity against the allergenic protein of A. suum (APAS-3) in a IL-10/IFN-γ dependent 
fashion [103,104,105]. 
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Fig. 4 Immune modulation by helminths. Worm infections commonly induce a Th2 immune response with high 
IgE levels, eosinophilia and mastocytosis. The release of cytotoxic substances by mast cells and eosinophils as 
well as antibody dependent cellular cytotoxicity can lead to killing of the parasite (upper panel). To prevent 
killing, helminths use different mechanisms to modulate the immune system for their purposes. Common traits 
are the induction of T regulatory cells, blocking IgG4 (mouse IgG1) antibodies and the expression of the regula-
tory cytokines IL-10 and TGF-ß (central panel). A bystander effect of helminth induced immune modulation is 
the interference with allergen induced allergic inflammation. Allergic inflammations are characterized by pro-
voking a similar, Th2 based, immune response as seen in helminth infections. A crucial step in the initiation of 
allergy is the allergen-specific activation of DCs. Epithelial cells play an important role in directly priming the DC 
via TSLP to become a Th2 promoting cell. The recruitment and activation of mast cells by release of SCF also 
supports a Th2 bias. Modulating effects of helminths can interfere with the induction and maintenance of aller-
gy at different levels. IL-10 and IgG4 interfere with antigen presentation by DCs and thereby the induction of 
Th2 T cells. DCs modulated by IL-10 fail to mature and release less inflammatory cytokines. T regulatory cells 
prevent the production of pro-inflammatory cytokines by releasing IL-10 and TGF-ß or a direct cell-cell interac-
tion. Moreover, blocking antibodies of the IgG4 subclass can prevent IgE based activation and degranulation of 
mast cells and eosinophils. Adapted from Schnöller, 2008 and Barnes, 2008 B: B cell, Th: T helper cell, DC: den-
dritic cell, Treg: T regulatory cell, Th2: T-helper cell 2, MHC class II: major histocompatibility complex II, Ig: im-
munoglobulin, IL: interleukin, TSLP: thymic stromal derived lymphopoietin, SCF: stem cell factor; TCR: T cell 
receptor; ADCC: antibody dependent cellular cytotoxicity 
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2.4 Aims 
 
Part I 
The aim of this part was to establish RNAi in H. p. bakeri using a protein with an easily de-
tectable phenotype. Tropomyosin was a promising candidate as it produces an easily detect-
able phenotype. Tropomyosin has also been used by others to establish RNAi and is reported 
to produce a strong phenotype in C. elegans [106,107] and in T. colubriformis [37].  
Part II 
The second part investigates the possible role of A. viteae tropomyosin in the modulation of 
the immune response to an unrelated allergen (Ovalbumin) in a rodent model of allergic air-
way inflammation  
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3 Results 
3.1 Part I – RNA interference in Heligmosomoides polygyrus bakeri 
3.1.1 Target gene and sequence fragments 
H. p. bakeri-tropomyosin (Hp-tmy) was chosen as a model target gene, because tropomyos-
ins have been successfully knocked down in several other organisms. To attempt RNAi in H. p. 
bakeri the complete sequence of Hp-tmy (cHp-tmy) with a length of 855bp including start 
and stop codon as well as a 165bp fragment (Hp-tmy-1) covering the 5’ end and a 273bp 
fragment (Hp-tmy-2) covering the 3’end was used (Fig. 5). dsRNA (Ec-malE) derived from mal-
tose-binding protein of E. coli (Ec-MBP) and dsRNA of the Ce-unc-22 gene were used for con-
trol treatments. The C. elegans unc-22 gene encodes for twitchin, a protein involved in mus-
cle regulation, and was used as positive control for C. elegans and negative control for H. p. 
bakeri, respectively.  
 
Fig. 5 Schematic illustration of H. p. bakeri tropomyosin (Hp-tmy) fragments used for RNAi. Hp-tmy-1 and 
cHp-tmy were used for feeding, Hp-tmy-1 and Hp-tmy-2 for soaking experiments; location of the Real-Time PCR 
primers is marked by opposing arrowheads. cHp-tmy: complete H. p. bakeri tropomyosin; Hp-tmy-1 & Hp-tmy-2: 
fragments of H. p. bakeri tropomyosin. 
 
3.1.2 Feeding of Hp-tmy dsRNA does not induce a phenotype in H. p. bakeri, but in  
C. elegans 
Initial tests revealed that E. coli HT115 (the strain producing recombinant dsRNA) supports 
the development of H. p. bakeri. The hatching rate and the proportion of larvae reaching the 
L3 stage were similar after feeding on lawns of E. coli HT115 as compared to lawns of E. coli 
OP50, the standard strain used for maintenance of H. p. bakeri larvae.  
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E. coli HT115 expressing cHp-tmy or Hp-tmy-1 dsRNA were fed to H. p. bakeri larvae. As con-
trols, H. p. bakeri were kept on lawns of E. coli HT115 expressing Ec-malE, Ce-unc-22 or no 
dsRNA. After seven days of feeding on recombinant bacteria the number of H. p. bakeri 
reaching the L3 stage did not significantly differ between the groups (Fig. 6a). Microscopic 
examination of vital L3 did not show differences in the morphology between the groups. 
Thus, keeping of H. p. bakeri larvae on lawns of E. coli HT115 expressing dsRNA of Hp-tmy 
failed to induce a phenotype.  
 
Fig. 6 Feeding of Hp-tmy dsRNA does not induce a phenotype in Heligmosomoides polygyrus bakeri but in 
Caenorhabditis elegans. (a) Shown is the development of H. p. bakeri eggs to L3. H. p. bakeri larvae were fed on 
bacteria expressing cHp-tmy or Hp-tmy-1 dsRNA, irrelevant dsRNA (Ec-malE, Ce-unc) or bacteria containing an 
empty L4440 plasmid (control). (b) Shown is the number of worms produced by a single C. elegans hermaphro-
dite upon treatment. C. elegans worms were fed on recombinant bacteria expressing dsRNA of cHp-tmy, Hp-
tmy-1 or Ce-unc-22 , irrelevant dsRNA (Ec-malE) or bacteria containing an empty plasmid (control). Error bars 
indicate the standard deviation of the mean of six independent experiments, (ANOVA, df=4, p<0,0001; Dunn’s 
post-hoc test, significant differences are denoted in the graph). (c) C. elegans developed body morphology de-
fects (bmd-phenotype) after feeding for three days on bacteria expressing Hp-tmy-1 dsRNA. Wild Type (WT): 
untreated hermaphrodite with complete organs. The reproductive tract shows the didelphic ovaries with highly 
structured oocytes and a uterus containing developing eggs. The intestine is filled with bacterial debris. Hp-tmy-
1: a hermaphrodite treated with Hp-tmy-1 dsRNA. The ovaries contain only rudimentary structures of oocytes. 
The uterus is empty or contains degraded eggs. The intestine is partly atrophied. white arrow: spermatheca; 
black arrow: vulva; white arrowheads: ovaries; black arrowhead: oocytes; black asterisk: developing eggs within 
the uterus; white asterisk: intestine; bar: 130 µm. 
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In contrast, feeding of the same recombinant E. coli HT115 expressing dsRNA of cHp-tmy or 
Hp-tmy-1 to C. elegans caused a significant reduction of progeny compared to the control 
groups (Fig. 6b). Moreover, morphological changes of C. elegans after feeding with cHp-tmy 
and Hp-tmy-1 dsRNA resembled the well described phenotypes seen in knock down mutants 
of C. elegans obtained by feeding on dsRNA of C. elegans tropomyosin (Ce-tmy), namely 
body morphological defects, sterility, embryonic arrest and abnormal egg laying (Fig. 6c). 
Feeding of the cHp-tmy dsRNA to C. elegans had the strongest impact. cHp-tmy dsRNA inhib-
ited the release of eggs and was finally lethal to the adults. Hp-tmy-1 dsRNA also showed 
significant effects on C. elegans but single hermaphrodites were still able to release low 
amounts of eggs resulting in a small number of offspring. Feeding of bacteria expressing Ce-
unc-22 dsRNA (positive control) to C. elegans also led to a reduced number of offspring (Fig. 
6b & 6c) and caused a “twitching” phenotype. 
An alignment of cHp-tmy with tropomyosin of C. elegans revealed 85% identity to the Ce-
tmy-I splicing form. Hence, feeding of C. elegans with cHp-tmy dsRNA resulted in a pheno-
type expected for knock down of tropomyosin, although the sequence identity between cHp-
tmy and Ce-tmy-1 is below 90%. The successful RNAi in C. elegans suggests that the tech-
nique works, and implies that the lack of a phenotype in H. p. bakeri must be owing to either 
an impeded uptake of RNA and/or a deficiency of elements of the RNAi machinery in the 
parasitic nematode.  
3.1.3 H. p. bakeri larvae ingest fewer bacteria compared to C. elegans larvae 
To determine the amount of bacteria taken up by H. p. bakeri as compared to C. elegans, 
GFP-expressing E. coli were fed to the respective larvae and the uptake was followed micro-
scopically. These experiments showed that C. elegans L1 larvae ingest substantially more bac-
teria than H. p. bakeri L1 (Fig. 7). Whereas C. elegans larvae continuously ingest bacteria, so 
that the pharynx is constantly filled with a green fluorescing mass, H. p. bakeri larvae only 
pick up single bacteria from time to time. These pass the oesophagus as single spots, before 
the fluorescence extinguishes when the bacteria reach the intestine. 
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Fig. 7 Heligmosomoides polygyrus bakeri larvae ingest fewer bacteria than Caenorhabditis elegans larvae. 
Shown are examples of a single L1 of each species fed on E. coli expressing the green fluorescent protein. The H. 
p. bakeri L1 takes up single bacteria (Hp, arrowhead), whereas the C. elegans L1 continuously takes up large 
amounts of bacteria (Ce, arrow); bar: 10 µm. 
 
3.1.4 Electroporation with siRNA does not induce a phenotype in adult H. p. bakeri  
To test whether electroporation is the method of choice larvae (L1) as well as adult worms 
were electroporated with available siRNAs labeled with the fluorescent dye Cy3 suspended in 
trehalose buffer previously used by Issa et al. [37] or commercial electroporation buffer (Am-
bion, Austin, USA). Electroporation of larvae resulted in massive death of 70-90 % of larvae 
irrespective of the conditions for buffer, voltage and time (see p. 79 Tab. 7). Electroporation 
with Cy3-labeled siRNA did not result in a detectable fluorescent signal within the larvae. 
Conversely, electroporation of adults with a single pulse of 20 ms @ 500V led to single spots 
of Cy3-siRNA between cuticle and hypodermis. However, these penetration events occurred 
rarely in relation to the worm size (Fig. 8).  
 
Fig. 8 Cy3-siRNA penetrates the cuticle of adult Heligmosomoides polygyrus bakeri upon electroporation.(a) 
Electroporation of adult H. p. bakeri with dye-labeled siRNA resulted in local uptake, but no spreading. (b) High-
er magnification shows the localization of the siRNAs between cuticle and hypodermis. (c) bright field of the H. 
p. bakeri worm shown in a). arrow: single fluorescent spot; white arrowhead: cuticle; black arrowhead: hypo-
dermis. a) 550 nm; bar: 500 µm b) 550 nm; bar: 40 µm c) bright field; bar: 500 µm. 
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3.1.5 Soaking with Hp-tmy dsRNA does not induce a phenotype in H. p. bakeri  
Larvae of H. p. bakeri do not lend themselves to soaking as L1/L2 exhibit a reduced lifespan in 
liquid media and L3 are physiologically inactive. Therefore adult worms were used for soak-
ing in dsRNA. To test whether RNA is taken up by soaking, adult H. p. bakeri worms were ex-
posed to Hp-tmy-1 dsRNA labeled with the dye Cy3. After 18 h of soaking the dsRNA accumu-
lated in the pharynx and to a minor extent in the intestine of adult worms (Fig. 9a). 
Fluorescence was visible in the lumen of the pharynx and also in the surrounding tissue, indi-
cating that dsRNA was taken up by cells. However, a systemic spread of dsRNA was not de-
tectable. Worms kept in RPMI without dsRNA did not show any fluorescence (Fig. 9b upper 
worm). 
 
Fig. 9 Soaking of Heligmosomoides polygyrus bakeri adults results in uptake of dsRNA into pharynx and gut. 
(a) Shown are two adult worms soaked in RPMI with and without Cy3-siRNA. No fluorescence was found in the 
control group (upper worm of a: -Cy3-dsRNA) whereas worms exposed to Cy3-labeled dsRNA showed strong 
fluorescence in the pharynx and weak fluorescence in the intestine (lower worm of a: +Cy3-dsRNA) highlighting 
the major side of uptake; bar: 1,7 mm. (b) The intestine also served as side of dsRNA-uptake visible at higher 
magnification. Panel b) also depicts the invasion of the dsRNA into the epithelial layer seen by the stronger 
fluorescence of the tissue compared to the lumen of the gut; bar: 0,7 mm, arrowhead: pharynx; arrow: intes-
tine. 
Next, adult worms were soaked in 2 µM dsRNA of Hp-tmy-1 and Hp-tmy-2, respectively, for 
different time periods and analyzed for potential morphological alterations. A soaking period 
of 24 h did not result in morphological changes compared to the control groups. Extended 
soaking for six days resulted in 37% of altered worms (p ≤ 0.05 as compared to the control  
group) (Fig. 10a) that showed particular morphological changes before dying. In female 
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worms, the ovaries and the gut were disintegrated and in some worms egg fragments were 
floating in the pseudocoelomic cavity (Fig. 10 b & c). These lesions did, however, not neces-
sarily stop the worms from moving. The proportion of damaged and subsequently dead 
worms was lower (16%) after soaking in Hp-tmy-2 dsRNA. However, also some worms  
 
Fig. 10 Soaking failed to induce RNAi in Heligmosomoides polygyrus bakeri adults. (a) Soaking of adult worms 
for 6 days in Hp-tmy dsRNA resulted in increased morbidity and increased ageing after treatment with Hp-tmy-1 
in comparison to untreated (control) and Ec-malE-treated worms. (b) and (c) Treatment with Hp-tmy-1 and Hp-
tmy-2 leads to a disintegrated gut and disrupted ovaries; bar: 2 mm. (d) Treatment with Hp-tmy-1 dsRNA did not 
induce significant changes in the expression of Hp-tmy compared to the Ec-malE control group analyzed by 
qPCR. (e) Treatment with Hp-tmy-2 led to an upregulation of the tropomyosin expression. (f) Treatment with Ec-
malE control dsRNA did not change the expression level of tropomyosin. Single worm qPCR revealed different 
expression levels between individuals upon treatment with dsRNA for 24 hours (g) or 6 days (h). Error bars indi-
cate the standard error of mean of six independent experiments, (ANOVA, df=4, p<0,05; Dunn’s post-hoc test, 
significant differences are denoted in the graph). Black arrow: vulva; black arrowhead: Uterus; white arrow-
heads: ovaries; white triangle: intestine; white asterisk: disrupted ovary; black asterisk: anterior end. 
treated with Ec-malE (10%) dsRNA and even a few control worms (7%) showed these altera-
tions. To correlate these morphological alterations with possible RNAi effects, the levels of 
tropomosin mRNA were analyzed by qPCR of worm pools cultured together in one well (Fig. 
10 d-f). Treatment with Hp-tmy-1 dsRNA did not significantly change the tropomyosin mRNA 
level after soaking for 24 h or 6 days, while treatment with Hp-tmy-2 dsRNA led to increased 
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mRNA levels after 6 days. The tropomyosin expression seen after soaking for 24 h or 6 d did 
not change substantially when worms were cultured for further 48 h in dsRNA free medium. 
Worms kept in Ec-malE dsRNA did not show significant alterations of tropomyosin mRNA 
levels. 
To analyze possible individual differences between worms, RNA of single females soaked ei-
ther 24 h (no morphological alterations) or 6 days (all with morphological alterations) was 
used to determine the expression levels of tropomyosin. These experiments revealed sub-
stantial individual differences between worms, particularly after soaking in Hp-tmy-1 (Fig. 10 
g & h). However, the levels of mRNA were not correlated with the degree of morphological 
alterations.  
3.1.6 BLAST analysis to identify RNAi-related orthologous in helminths 
As feeding, electroporation and soaking of H. p. bakeri did not yield a clearly visible pheno-
type, the question stand to reason whether this failure could be due to the absence of genes 
required for uptake and/or processing of dsRNA. To address this hypothesis the EST database 
of the closely related ruminant nematode Haemonchus contortus, the genome database of 
the filarial nematode B. malayi as well as the EST database of the trematode Schistosoma 
mansoni was searched for sequences homologous to 18 RNAi related proteins of C. elegans 
(Tab. 1). Out of 18 C. elegans sequences only six showed significant homologies to genes in 
the H. contortus database, ten to B. malayi sequences and seven to sequences in the S. man-
soni genome database.  
RNAi proteins can be divided into different subclasses for uptake, processing, mRNA regula-
tion, amplification, and degradation of dsRNA (see Tab. 1). For H. contortus, no matches were 
obtained for proteins involved in RNA-uptake (SID-1, SID-2) and dsRNA-regulation (ERI-1). 
Best matches for H. contortus proteins were obtained for proteins belonging to dsRNA-
processing (DICER, DRH-1) and dsRNA-amplification (RRF-1, EGO-1, RDE-3) and mRNA regula-
tion (TSN-1) class. For B. malayi and S. mansoni similar results were obtained with some ad-
ditional sequences (see Tab. 1) including one homologous sequence encoding for a protein 
involved in RNA-spreading (RSD-3). 
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In summary none of the used transfection methods for RNAi - feeding, electroporation and 
soaking - yield a clear phenotype. Only soaking resulted in a locally confined alteration of 
adult worms. The local restriction might be explained by the finding that the Genome of H. 
contortus, a close relative of H. p. bakeri, does not contain certain components of the RNAi 
machinery necessary of an effective and systemic knock down.  
  
Tab. 1 Analysis of core proteins of RNAi in three different genomes; The EST database of H. contortus (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/h_contortus), the 
WGS database of B. malayi (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) and the GAV3 database of S. mansoni (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/s_mansoni) 
were searched for orthologous proteins of the RNAi pathway of C. elegans by tBLASTn. Sequences with a p-value below e-5 were designated as probably homologue. Homolo-
gues sequences were subsequently used to search for conserved domains in the conserved domain database available on NCBI 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi. EST, expressed sequence tag; WGS, whole genome shotgun; GAV3, genome assembly version 3; CDD, conserved domain 
database; RdRP, RNA dependent RNA polymerase 
C. elegans H. contortus B. malayi S. mansoni 
 Gene Function / Phenotype Ref. EST CDD WGS CDD GAV3 CDD 
    P-value Homologues Domain P-value Homologues Domain P-value Homologues Domain 
U
pt
ak
e 
sid-1 Uptake of dsRNA into cells and spread between cells [28,30,31,108] 0,9997 ----- 0,0005 ----- 0,0067 ----- 
sid-2 Uptake of dsRNA from the intestine [35] ----- ----- 0,9997 ----- 0,2 ----- 
rsd-2 Silencing defect in germline cells [27] ----- ----- 0,9  0,13 ----- 
rsd-3 Silencing defect in germline cells [27] 0.085 ----- 5.0e-18 ENTH_epsin 3e-16 ENTH_epsin 
rsd-4 Silencing defect in somatic and germline cells     No sequence data available   
rsd-6 Silencing defect in germline cells [27] 0.55 ----- ----- ----- 0.0026 ----- 
Pr
oc
es
si
ng
 
dcr-1 Ribonuclease [109,110] 1.9e-42 HELICc/PAZ/DSRM 8.2e-45 RIBOc, PAZ_dicer_like, DEXHc 4.9e-34 
RNAse III, DSRM, PAZ, 
HELICc, DEXHc 
drh-1 Helicase; required for somatic and germline RNAi [110] 1.3e-15 DEXHc/HELICc 3.1e-18 HELICc, Type III restriction enzyme 1.1e-08 DEXHc 
rde-1 Accumulation of dsRNA [34] 0,66 Piwi/ago 1.6e-10 DEXDc, Piwi_ago-like 1.0e-17 PIWI, PIWI-ago 
rde-4 dsRNA recognition and binding protein [34] ----- ----- ----- ----- ----- ----- 
m
RN
A
 R
eg
ul
at
io
n tsn-1 Nuclease [111] 2.7e-66 Tudor 6.2e-46 Tudor 4.0e-108 Tudor 
vig-1 predicted RNA-binding protein [111] 0.9994  3.2e-20 mRNA binding family ----- ----- 
rde-2 functions downstream of rde-1 [112,113] ----- ----- 0.78 ----- ----- ----- 
mut-7 RnaseD; required for RdRP and [114]   0.0035 ----- ----- ----- 
A
m
pl
ifi
ca
tio
n rrf-1 for somatic RNAi [115] 6,6e-16 ----- 2.0e-42 RdRP ----- ----- 
ego-1 RdRP [116] 8,7e-20 ----- 1.2e-43 RdRP 0,9993 ----- 
rde-3 Nucleotidyltransferase; function in RNAi unknown [117] 9.1e-15 ----- 7.8e-09 ----- 7.0e-05 poly(A) polymerase 
 eri-1 Exonuclease; degrades siRNA [118] 0.992 ----- 2.6e-20 Exonuc_X-T, EXOIII 1.4e-30 exonuclease 
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3.2 Part II – Influence of rAv-TMY on a murine model of allergic airway 
inflammation 
In order to investigate possible functions of filarial derived tropomyosin in modulating in-
flammatory immune responses, rAv-TMY was applied in an in vivo model of OVA induced 
airway inflammation. To provoke an allergic response the mice were sensitized two times 
with OVA/Alum intraperitoneally and subsequently challenged by administration of OVA into 
the airways. A preventative model was used in which the treatment can possibly interfere 
with the sensitization phase. Mice were treated four times with 20 µg E. coli expressed Av-
TMY or the mouse derived control protein dihydrofolate reductase (DHFR) over a period of 
three weeks, challenged twice with OVA at day 28 / 29 and scarified at day 32 (Fig. 11). 
 
Fig. 11 Model of a murine allergic airway inflammation. The scheme presents a preventative model allowing 
the interference of rAv-TMY with the onset of the allergic inflammation. Animals were sensitized two times with 
20 µg OVA-Alum and in parallel treated four times with 20 µg rAv-TMY. 28 days after the first sensitization, air-
way inflammation was induced by two intranasal applications of 50 µg OVA. Two days later animals were dis-
sected. i.p. intraperitoneal, i.n. intranasal 
 
3.2.1 rAv-TMY modulates airway hyperresponsiveness 
Sensitization and challenge of mice with OVA induced a strong Th2 biased immune response. 
This was reflected by mucus hypersecretion, a massive cell influx into the airways, a strong 
OVA specific IgE response and a Th2 cytokine environment. Application of rAv-TMY but not 
rDHFR induced changes in a way that the immune reaction in the lung was less responsive to 
provocation by OVA. Several parameters were analyzed. 
First, the cell composition in the bronchoalveolar lavage fluid (BALF) was analyzed mainly in 
regard to eosinophils, a main effector cell in allergic airway diseases. rAv-TMY abated the cell 
influx into the lung after challenge with OVA. Treated animals showed significantly reduced 
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total cell numbers (p = 0,007), significant less lymphocytes (p = 0,0048) and significantly re-
duced numbers of eosinophils (p = 0,01) in the BALF (Fig. 12). 
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Fig. 12 rAv-TMY abate cell influx into the airway lumen. rAv-TMY treatment resulted in a significant reduction 
of total cells, lymphocytes and eosinophils within the BALF. Mice were sensitized with OVA-Alum or PBS and 
treated with PBS, rAv-TMY or rDHFR respectively. 32 days post first treatment animals were scarified, the lungs 
lavaged with PBS and the cells in the BALF differentiated in a cytospin preparation. Error bars indicate standard 
error of mean of two independent experiments with 6-7 animals per group (ANOVA p ≤ 0,05, Mann Whitney 
test, *p ≤ 0,05, **p ≤ 0,01); BALF bronchoalveolar lavage fluid 
The reduction of eosinophils was also reflected in the airway interstitium seen by histological 
sections (Fig. 13). Both sensitized only and rAv-TMY treated animals had large cell infiltra-
tions around the vessels and bronchioles compared to PBS treated. However, rAv-TMY 
treated animals showed lower no. of eosinophils within these cell infiltrations. 
 
Fig. 13 Eosinophil migration to the airway interstitium is reduced by rAv-TMY treatment. HE staining of lung 
sections showed large cell infiltration around the vessels and bronchioles in only sensitized and treated animals 
but with a smaller proportion of eosinophils in treated vs. only sensitized animals seen at higher magnification 
(white arrows). 32 days post first treatment animals were sacrificed, lungs flushed with PBS to remove excessive 
blood from the vessels and conserved in 3,5% formalin. Paraffin embedded slices were HE stained. bar: 100 µm, 
HE: hematoxylin and eosin 
Second, the influence of rAv-TMY on the IgE response as a central maker for allergic re-
sponses was investigated. Total IgE levels were lowered in treated animals without reaching 
significance. In contrast OVA specific IgE production was significantly inhibited by rAv-TMY 
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treatment compared to animals sensitized only with OVA (p< 0.0001) or treated with rDHFR 
(p=0,0075) (Fig. 14).  
 
 
Fig. 14 OVA specific IgE production is inhibited by rAv-TMY treatment. rAv-TMY diminished total IgE produc-
tion compared to OVA or rDHFR treated animals without reaching significance (a). OVA specific IgE levels were 
significantly reduced compared to the OVA or rDHFR group (b). In the PBS group hardly any IgE was detectable 
(a & b). IgE content was measured in a sandwich ELISA. OVA spec. IgE was analyzed using biotynilated OVA as 
secondary reagent and values are expressed as lab units (LU). Error bars represent standard error of mean of 
two independent experiments with groups of 6-7 animals (ANOVA p ≤ 0,05, Mann Whitney test, **p ≤ 0,01, 
***p < 0,001) 
Third, mucus production as a clinical relevant parameter was altered by rAv-TMY. Analysis of 
histological sections showed reduced mucus production in the large airways between rAv-
TMY treated and control animals as seen by PAS staining for mucin (Fig. 15).  
 
Fig. 15 Mucus production is reduced by rAv-TMY treatment. Staining of lung sections with PAS revealed a re-
duced mucin production (purple color) by goblet cells in bronchi and bronchioles of rAv-TMY treated compared 
to sensitized only animals. PBS treated animals did not produce any mucin (a). bar: 100 µm, PAS: periodic acid-
Schiff 
Both specific immunotherapy (SIT) as well as helminth infections are shown to alter the pat-
tern of immunoglobulin G subclasses. To address the question if rAv-TMY is able to modulate 
IgG responses antigen specific subclass ELISA’s were performed. rAv-TMY treated animals 
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develop a strong rAv-TMY specific IgG1 (human IgG4) response (Fig. 16a). In contrast OVA 
sensitized and challenged animals showed a modest induction of OVA specific IgG1 that was 
not altered by rAv-TMY treatment (Fig. 16b). Similar effects were observed concerning the 
other immunoglobulin subclasses IgG2a (human IgG1) and IgG2b (human IgG3) (Fig. 16 c & 
d). The sera levels of both subclasses responding to rAv-TMY were elevated in rAv-TMY 
treated animals but almost no IgG2a or IgG2b antibodies against OVA (data not shown) could 
be detected. In summary rAv-TMY induced a strong specific IgG response accompanied by an 
abated allergen specific IgE response. 
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Fig. 16 Changes in the composition of IgG subclasses in sera induced by rAv-TMY. The graphs depict three 
different IgG subclasses found in sera of mice. A strong IgG1 response specific for rAv-TMY was observed in the 
rAv-TMY group (a) whereas OVA did not induce specific IgG1 antibodies (b). A similar effect was found for IgG2a 
(c) and IgG2b (d). Antibodies were detected by ELISA using subclass specific detection antibodies. Error bars 
indicate standard error of mean for a representative experiment with 7 animals per group (ANOVA p ≤ 0,05, 
Mann Whitney test, *p < 0,05, **p ≤ 0,01). n.d.: not detectable 
Next it was of interest if the local and systemic cytokine pattern were affected by rAv-TMY. 
Cytokines are of importance for the local orchestration of allergic airway inflammation. The 
Cytokine composition of BALF was analyzed using a cytometric bead array (CBA). The Th2 
cytokines IL-5 and to lesser extent IL-13 were found in lower concentrations in rAv-TMY 
treated animals whereas the IL-4 levels showed no differences compared to the control 
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groups. With regard to IL-13 the control protein rDHFR had also an inhibiting effect. The 
regulatory cytokine IL-10 remained the same expression in all groups (Fig. 17d) and the Th1 
cytokine IFN-γ was below the detection limits (data not shown). 
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Fig. 17 Cytokine pattern in the BALF changes in response to rAv-TMY. Cytokines in the BALF were measured by 
CBA. IL-5 and IL-13 secretion was prominently induced in OVA only sensitized animals. This effect was reduced 
by half in rAv-TMY treated animals. No differences between the groups could be detected for IL-4 and IL-10. 
Error bars indicate standard error of mean of 3 animals per group; BALF bronchoalveolar lavage fluid  
Since allergic reactions are mostly dominated by Th2 cytokines the question arises whether 
this cytokines are altered by a rAv-TMY treatment also in a systemic manner. In addition the 
expression of the regulatory cytokine IL-10 and the Th1 cytokine IFN-γ was measured. Re-
garding the Th2 cytokines both OVA and rAv-TMY induced IL-4, IL-5 and IL-13 as well as the 
regulatory cytokine IL-10 in the spleen. In contrast IFN-γ was only expressed by spleen cells of 
rAv-TMY treated animals in response to the same antigen (Fig. 18).  
  
Results 38 
IL-4
0
50
100
150
[p
g/
m
l]
IL-5
0
200
400
600
800
[p
g/
m
l]
IL-13
0
1000
2000
3000
4000
5000
[p
g/
m
l]
IL-10
0
1000
2000
3000
4000
5000
[p
g/
m
l]
IFN-γ
0
100
200
300
400
[p
g/
m
l]
OVA specific
IL4
0
50
100
150 **
[p
g/
m
l]
IL-5
0
200
400
600
800 **
[p
g/
m
l]
IL-13
0
1000
2000
3000
4000
5000 **
[p
g/
m
l]
IL-10
0
1000
2000
3000
4000
5000 **
[p
g/
m
l]
IFN-γ
0
100
200
300
400
500 ***
[p
g/
m
l]
rAv-TMY specific
PBS / PBS OVA / OVA OVA / rAv-TMY
 
Fig. 18 rAv-TMY and OVA induced cytokine responses by restimulated splenocytes. Splenocytes were restimu-
lated with either OVA (OVA specific) or rAv-TMY (rAv-TMY specific) and cytokine content in the supernatant was 
measured by ELISA. Error bars indicate standard error of mean of a representative experiment with 6 animals 
per group. (ANOVA p ≤ 0,05, Mann Whitney test, **p ≤ 0,01, ***p < 0,001) 
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Similar to cytokines, chemokines play an important role in the cell recruitment, cell activa-
tion and particularly in the micro environmental allocation of cells in the airways. To unravel 
the chemokine expression lung tissue was analyzed by quantitative real-time PCR. Expression 
of CCL11, CCL12 and CCL24 - three main chemokines attracting and guiding eosinophils - 
were drastically reduced in treated animals vs. non-treated (Fig. 19). CCL12 is also a 
chemoattractant for monocytes. Other chemokines and receptors known to play a role in 
eosinophil recruitment and tethering such as VCAM-1, CCR3, CCL2 and CCL5 were not influ-
enced by rAv-TMY treatment (data not shown). 
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Fig. 19 rAv-TMY abrogates expression of chemokines in the airways induced by OVA . The graph illustrates the 
relative gene expression of the indicated chemokines compared to PBS treated animals. CCL11 (Eotaxin-1), 
CCL24 (Eotaxin-2) and CCL12 (MCP-5) are responsible for the recruitment and distribution of eosinophils. All 
three chemokines were upregulated in OVA sensitized animals, an effect that was abrogated in rAv-TMY treated 
animals. Ct values were normalized against endogenous control and expressed as fold change to PBS treated 
group (analyzed with StatMiner). Error Bars indicate standard deviation of a group with six animals. RQ: relative 
quantification, CCL: chemokine (CC-motif) ligand, MCP: monocyte chemotactic protein 
Several parasites and consequently their released molecules have been shown to modulate 
the host immune system by inducing regulatory T cells. Therefore it was of interest if rAv-
TMY also promotes the development of regulatory T cells and their accumulation in the lung 
draining lymph nodes. To investigate this question the numbers of CD4+CD25+CD103+ cells in 
the draining lymph nodes was measured by FACS. Most CD4+ T cells express the IL-2 receptor 
CD25 on their surface. Activated regulatory T cells which preferentially migrate to sides of 
inflammation additionally express the activation marker CD103. Only a minor difference be-
tween naïve animals versus OVA or rAv-TMY treated animals but no difference between the 
OVA versus rAv-TMY treated animals was observed. These findings suggest that the amelio-
rating effects of rAv-TMY are not due to activated Tregs within the PBLNs (Fig. 20). 
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Fig. 20 rAv-TMY does not change the frequency of activated Treg cells in then PBLNs. Shown is the proportion 
of CD4+ T cells that express the IL-2 receptor CD25 and the activation marker CD103 in the lung draining lymph 
nodes (PBLNs). Neither sensitization alone nor the combination with rAv-TMY treatment changed the propor-
tion of CD25+CD103+ cells in the CD4+ compartment compared to PBS treated animals. Graph represents a 
group with six animals. Boxes indicate interquartile range and median. Whiskers represent min and max values. 
Immunoglobulin A is the main mucosal antibody and shown to be involved in the activation 
of eosinophils. IgA is described to have activating and inhibitory functions in humans but the 
definite role in asthma is unclear. Nevertheless, it was of interest if rAv-TMY would change 
the IgA content of BALF and serum. rAv-TMY treated animals secreted significant less total 
IgA into the BALF compared to OVA sensitized only animals (p = 0,039) (Fig. 21) whereas sera 
IgA was unchanged in all groups (data not shown).  
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Fig. 21 rAv-TMY inhibits secretion of IgA in bronchoalveolar fluid. The graph depicts the concentration of se-
creted IgA in the BALF. Mice that received rAv-TMY secreted significantly less IgA into the airway lumen then 
mice only sensitized. A reduction in IgA levels was also seen in rDHFR treated animals although it did not reach 
significance. Total IgA was measured by ELISA. Error bars indicate standard error of mean of two independent 
experiments with 6-7 animals per group (ANOVA p ≤ 0,05, Mann Whitney test, *p ≤ 0,05); BALF bronchoalveolar 
lavage fluid 
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3.2.2 rAv-TMY affects migration and TLR-2 expression of macrophages 
The intraperitoneal application of rAv-TMY has to influence somehow the immune system to 
create the effects seen in the asthma model. Preliminary in vitro studies showed a TLR-2 / 
MyD88 dependent induction of IL-10 by rAv-TMY in macrophages. Moreover, there are stud-
ies correlating TLR-2 expression and decreased susceptibility to allergies and reports on 
helminth derived molecules acting via TLRs. This led to the speculation that the immune 
modulation seen by rAv-TMY treatment might by mediated by macrophages in a TLR-2 de-
pendent mechanism. To address these question mice were injected with tropomyosin and 
rDHFR as control molecule. 18 h afterwards the PECs were analyzed in regard to the cell 
composition. Macrophages (F4/80high) were additionally analyzed in respect to TLR-2 and 
MHC class II expression. As presented in Fig. 22 treatment with rAv-TMY lead to a nearly 
complete loss of F4/80highGr-1- expressing cells (macrophages) in the peritoneum in compari-
son to naive animals. Treatment with rDHFR also reduced this cell population, however, not 
as drastic as rAv-TMY. Analyzes of the TLR-2 expression on F4/80highGr-1- cells revealed a sig-
nificant increase of TLR-2 expressing macrophages in the rAv-TMY group compared to the 
naive or rDHFR treated group. Macrophages of rAv-TMY treated animals expressed high lev-
els of MHC class II compared to PBS or rDHFR treated mice showing a higher activation status 
(data not shown). The results of this study clearly indicate that macrophages are induced by 
rAv-TMY to express high amounts of TLR-2 and that these cells emigrate from the perito-
neum into different tissues. 
In summary this work demonstrates that rAv-TMY induced a systemic Th2 response in an 
inflammation model indicated by the expression of IL-4, IL-5 and IL-13 but most importantly 
induced also regulatory IL-10 and the Th1 cytokine IFN-g. Strikingly, rAv-TMY abates mucus 
hypersecretion and cell influx in the airways and leads to a modified Th2 response in the local 
airways indicated by reduced IL-5 but increased IL-4 and unchanged IL-10 expression. Appli-
cation of rAv-TMY strongly induced TLR-2 expression on macrophages which started to emi-
grate from peritoneum. TLR-2 signaling on macrophages is therefore a likely mechanism by 
which rAv-TMY induce immune modulation. 
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Fig. 22 rAv-TMY induces TLR-2 expression on macrophages and efflux of these cells from the peritoneum. 
PBS, rAv-TMY or rDHFR were injected into the peritoneum of mice and the peritoneal exudate cells were ana-
lyzed by FACS for expression of F4/80 and TLR-2 after 18h. a) Dot plot of PECs of one representative animal 
treated with rAv-TMY. b) Proportion of F4/80highGr-1- (macrophages) of all PECs. c) Shown is a histogram of TLR-
2-PE labeled F4/80high cells and a PE-isotype (irrelevant antibody) control. A shift to the right indicates a higher 
expression of TLR-2, leading to an increased fluorescence intensity of labeled cells. d) Mean fluorescent intensi-
ty of anti-TLR-2 labeled macrophages. Error bars indicate standard error of mean of 5-6 animals per group. 
(ANOVA p ≤ 0,05, Mann Whitney test, **p ≤ 0,01, ***p < 0,001) 
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4 Discussion 
Worms are important parasites because of their ability to modulate the host immune re-
sponse and in succession also diseases. Tools to manipulate helminths will help to dissect the 
mechanisms of helminth immune modulation. First, this work used tropomyosin to investi-
gate the potential to use RNA interference as a tool to knock down genes in the murine 
strongylid H. p. bakeri. Second, filarial tropomyosin was used to reveal its potential immu-
nomodulatory capacities of this molecule in a murine model of allergic airway diseases.  
The data presented in the first part of this work disclose RNAi to be a rather inapplicable 
method for reverse genetics in strongylids and probably also other parasitic nematodes of 
mammalians. The fact that parasitic nematodes obviously missing certain proteins of the 
RNAi machinery has wide implications discussed later on. 
Second, the data on treatment with rAv-TMY in a murine asthma model revealed an immu-
nomodulatory function of this molecule which will be discussed in the second part. 
4.1 Part I – RNA interference in Heligmosomoides polygyrus bakeri 
This work aimed to establish a method to genetically manipulate parasitic nematodes in or-
der to have a tool which allows to study the immunomodulatory functions of single helminth 
derived molecules in vitro and in vivo. The potential use of the main delivery methods for 
RNAi – feeding, electroporation and soaking was explored. None of them yield a clear pheno-
type nor reduced levels of tropomyosin mRNA, indicating an insufficient uptake of dsRNA 
and/or a malfunctioning RNAi machinery.  
The feeding method, which is well-established for C. elegans, was of particular interest as it 
allows H. p. bakeri to develop under nearly natural conditions on a bacterial lawn. However, 
feeding of recombinant bacteria did not induce RNAi in H. p. bakeri although both Hp-tmy 
dsRNAs used exhibited a strong impact on development, morphology and morbidity of C. 
elegans. Sequence alignment of the fragment Hp-tmy-1 with the isoform CeTM1 of C. ele-
gans revealed 88% identity, while Hp-tmy-2 had 85% identity to CeTM1. Mismatches be-
tween the H. p. bakeri and C. elegans tropomyosin sequence were distributed over the com-
plete sequence with a bias towards the 3’ end. According to the dsRNA restriction by DICER it 
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is very likely that the resulting siRNAs contained one or more mismatches to the respective C. 
elegans mRNA. Therefore, our results support that induction of RNAi in C. elegans is not de-
pendent on 100% sequence identity between siRNA and target mRNA as suggested by Jack-
son et al. [119]. Induction of a strong phenotype in C. elegans, but not in the homologous 
system, could have several reasons: (i) the RNA was not efficiently delivered to the gut of the 
worms, (ii) the RNA delivered to the gut was not taken up into the tissues, and/or (iii) later 
steps of RNAi did not work in H. p. bakeri. Another factor to be considered is the fast turn-
over of proteins within the short life-cycle of C. elegans, making the free living nematode 
possibly more susceptible to the consequences of RNAi as compared to H. p. bakeri. For C. 
elegans it was found that the genes responsible for dsRNA uptake are mainly expressed in 
the intestine [28,31,35] and, that the concentration of dsRNA in the environment is impor-
tant for effective RNAi [30,31,35]. The fact that H. p. bakeri L1 take up only a fraction of re-
combinant bacteria ingested by C. elegans L1 leads to a much lower exposure of H. p. bakeri 
L1. In addition, C. elegans feeds constantly on bacteria throughout all life stages, whereas H. 
p. bakeri takes up bacteria only in certain phases of the life cycle, namely in the L1 and L2 
stage. However, the reduced exposure to bacteria would not completely exclude uptake of 
dsRNA through the intestinal wall. Therefore, additional factors like deficiencies of specific 
RNA transporters or other downstream elements of the RNAi machinery could contribute to 
the failure of RNAi by feeding in H. p. bakeri. Our results are in accordance with the report of 
Geldhof et al. [44] who did not obtain a phenotype by feeding of dsRNA of different genes 
including paramyosin to H. contortus larvae. In contrast, Issa et al. reported on a develop-
mental retardation of T. colubriformis larvae after feeding of tropomyosin dsRNA [37]. It is 
possible that this nematode takes up more bacteria as compared to H. p. bakeri, thus allow-
ing penetration of dsRNA into the gut epithelium in quantities sufficient to cause RNAi.  
As a second method electroporation was used to apply RNA. The structure mostly exposed to 
electroporation is the multi layered nematode cuticle, an acellular product shed by hypo-
dermal cells. As transport of low molecular substances through the cuticle has been de-
scribed in Brugia pahangi, Dirofilaria immitis and A. suum [120,121,122] we hypothesized 
that passage of siRNAs through the cuticle might deliver the molecules to the hypodermis. 
Electroporation was lethal to a large proportion of larval stages although a variety of condi-
tions were used and no penetration of dye labeled RNA was observed. These results are in 
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contrast to Issa et al. who showed a developmental retardation of T. colubriformis L3 upon 
electroporation with siRNA [37]. Along the same lines, Geldhof et al. showed a reduction of 
the transcript level by qPCR for the two genes Hc-ben-1 (ß-tubulin) and Hc-sod-1 (superoxide 
dismutase) after electroporation of H. contortus L1/L2 stages, but did not describe pheno-
typic effects due to the high proportion of dead larvae produced by this method [44]. It is 
possible that H. p. bakeri larvae have a particularly strong cuticle that does not allow the 
penetration of dsRNA. However, our study shows that electroporation of adult H. p. bakeri 
with labeled siRNA resulted in locally restricted signals within the cuticle. This indicates that 
electroporation has the capacity to penetrate a cuticle but the efficiency is probably too low 
for systemic RNAi. In contrast, the pre-adult stage of the trematode S. mansoni, the schisto-
somulum, which possess a tegument instead of a cuticle shows a robust phenotype after 
electroporation and is therefore more susceptible to RNAi via electroporation [123,124,125]. 
As a third approach soaking, a method that has recently been used for RNAi with the 
strongylids T. colubriformis and H. contortus was used [37,44]. Soaking of dsRNA is only appli-
cable to parasite life stages that can be cultured in liquid media. L1 and L2 stages of H. p. 
bakeri develop best on solid media ([44], own unpublished results). The L3 is a kind of 
“dauer-stage” that has a less active metabolism and we considered it to be an inappropriate 
target for RNAi after disappointing preliminary experiments with sheathed and exsheathed 
L3 (data not shown). Soaking of adult worms showed that the pharyngeal region, and to a 
minor extent the intestine, was filled with dye labeled material. However, a spreading into 
other organs or the pseudocoelomic cavity was not detectable, making a systemic RNAi 
unlikely. Nonetheless, soaking of adults in dsRNA for at least 6 days resulted in increased 
numbers of dead and damaged worms. The damaged worms resembled very much C. ele-
gans after treatment with Hp-tmy-1 or Hp-tmy-2 dsRNA or treatment with Ce-tmy dsRNA 
described in literature [106,107]. However, as these morphological changes only occurred 
after 6 days of in vitro culture, and were then also seen in the control groups (although to a 
much lesser extent), it was suspected that the alterations could also be age-related. Indeed, 
ageing C. elegans showed a similar phenotype (data not shown). Furthermore, a disinte-
grated gut and disintegrated ovaries of still living female nematodes were also reported for 
old Onchocerca volvulus worms [126]. This view was supported by the fact that the occur-
rence of morphological alterations was not correlated with reduced levels of tropomyosin 
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RNA after soaking. In addition, tropomyosin mRNA levels of single worms soaked with Hp-
tmy-1 or Hp-tmy-2 and showing morphological changes (day 6) varied widely. Therefore, no 
correlation between altered morphology and mRNA levels could be established on the levels 
of individual worms. Our observations are compatible with a relatively inefficient and local 
uptake of dsRNA that would result in local damage of the gut by RNAi. As a consequence 
treated worms might have suffered from more stress than the control groups, which might 
have led to increased ageing, but not to a specific phenotype. The reasons for an increase of 
transcript levels in Hp-tmy-2 treated worms are unclear. A similar effect was also reported by 
Geldhof when H. contortus L3 where electroporated or soaked in Hc-vha-10 dsRNA targeting 
the vacuolar ATPase [44]. One possible explanation is a feedback regulation that senses the 
decrease of the transcript level of a certain gene and reacts with enhanced transcription. 
However, other groups reported a clear down regulation of the transcript level in parasitic 
nematodes upon dsRNA treatment [39,127]. 
Successful RNAi depends on a complex protein machinery. The failure to produce a pheno-
type by RNAi in H. p. bakeri might be due to the absence of certain of these elements. This 
question was addressed by a database search for proteins that are part of the RNAi machin-
ery. Since no genome information for H. p. bakeri is available the expressed sequence tag 
(EST) database of the closely related strongylid H. contortus for orthologs of C. elegans RNAi 
related proteins was searched. The most prominent proteins found belong to protein com-
plexes involved in dsRNA-processing (DICER), mRNA-degradation (RISC) and dsRNA-
amplification (RdRP) [32]. 
However, the database did not contain orthologs for SID-1 (uptake and spreading), SID-2 (up-
take) or RSD-3 (spreading) [27,31,32,35]. Hence, the presence of the RNAi core proteins and 
the absence of dsRNA uptake proteins suggest that RNAi could occur in strongylid nematodes 
if the problem of uptake could be overcome. Without a system for spreading of dsRNA, the 
effects of RNAi could, however, be local and confined to accessible and sensible organs like 
the gut. The lack of uptake and/or spreading system would explain the paucity of reports on 
successful RNAi in parasitic strongylids. Hussein et al. could knock down two different acetyl-
cholinesterases (AChEs) in Nippostrongylus brasiliensis detected by a decrease in enzymatic 
activity [128]. T. colubriformis was reported to be most susceptible to RNAi when larval 
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stages were electroporated with siRNAs of ubiquitin [37]. This finding supports our hypothe-
sis that parts of the machinery for RNAi are present in parasitic nematodes and can act if the 
missing uptake proteins are replaced by an invasive delivery method like electroporation. 
This is also supported by a extensive study performed by Geldhof et al. [44]. Out of 11 genes 
of H. contortus larvae only two genes, encoding for ß-tubulin and superoxide dismutase 
could be knocked down, when larvae were electroporated or soaked, whereas feeding failed 
completely. Furthermore, a previous report showed a clear down regulation of two tubulin 
mRNAs of H. contortus upon soaking of L3, L4 and adults with dsRNA fragments [127].  
Our data support the notion that dsRNA is not efficiently taken up, but can be processed by 
H. p. bakeri, which is in line with the results presented by others [44,129,130]. Obviously, 
uptake and spreading of dsRNA is important, but factors such as sequence specificity, high or 
low gene expression, stage specific expression, stability of the target protein or strength and 
structure of the cuticle are likely to influence whether RNAi induces a phenotype or not in 
nematodes. Filarial nematodes for example are known to take up low molecular weight nu-
trients via their cuticle [120,121,122] and might be more capable to acquire high amounts of 
dsRNA although they do not possess the specific uptake proteins SID-1 and SID-2 as indicated 
by our results (see p. 32 Tab. 1) and others [131]. The few publications on filarial nematodes 
suggest a functioning RNAi machinery. Treatment of adult B. malayi with dsRNA via soaking 
of two housekeeping genes led to the reduction of the respective mRNA level and was lethal, 
and treatment with dsRNA of a microfilarial sheath protein inhibited proper sheath forma-
tion [36]. Furthermore, Pfarr et al. demonstrated RNAi in adult Litomosoides sigmodontis and 
proved off target effects using high concentration (>3.5M) of dsRNA via soaking experiments 
[39]. A reduced lifespan and inhibition of molting was observed via soaking of A. viteae in 
dsRNA targeting chitinase [132] and also L3 of O. volvulus failed to molt after soaking in 
cathepsin-L and -Z dsRNA [38]. The latter authors propose a transfer of dsRNA through the 
cuticle, since some of the L3 showed a signal in the hypodermal region after exposure to la-
beled dsRNA. In this respect it is interesting that our database analysis revealed that B. ma-
layi exhibits a gene with similarities to the rsd-3 of C. elegans [32]. RSD-3 comprises an epsin 
N-terminal homology domain (ENTH) that belongs to a family of endocytic adaptor proteins, 
which are thought to be involved in vesicle trafficking. In C. elegans RSD-3 is specifically i n-
volved in systemic RNAi of exogenous dsRNA [27,29,32]. Thus, it is possible that RSD-3 plays 
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the same role in filarial nematodes and makes them more amenable to RNAi. This might also 
be true for trematodes such as S. mansoni, in which the rsd-3 gene is present (see Tab. 1). S. 
mansoni was reported to produce a long lasting and reproducible phenotype by electropora-
tion with dsRNA of cathepsin B and alkaline phosphatase [123,124,133].  
4.2 Part II – Influence of rAv-TMY on a murine model of allergic airway 
inflammation 
Generally helminth infections induce a Th2 response to which the parasites have become 
adapted in a way that they are able to modulate this otherwise harmful immune response 
[53,134,135,136]. The modulating properties of helminths include the modulation of the 
antibody response, induction of IL-10 and TGF-ß production and the expansion and differen-
tiation of regulatory T cells [137,137,138,139]. One evolutionary trait that developed to inter-
fere with the host immune response is the release of modulating molecules. A few of the 
responsible products released by different helminth parasites have been characterized 
[50,60,99,102]. However, the detailed mechanisms how helminths modulate the host im-
mune reaction remains barely understood. This study aims to reveal the potentially immu-
nomodulatory functions of A. viteae tropomyosin a molecule otherwise shown to be an al-
lergen [140,141]. The fact that filarial nematodes persist in their respective hosts for a long 
time in general without inducing signs of severe allergic reactions led to the speculation that 
filarial tropomyosin might have lost the immunogenic capacity seen in invertebrates of other 
phyla. Furthermore preliminary in vitro studies revealed IL-10 inducing capacity of A. viteae 
tropomyosin. This indicates a potential regulatory function of Av-TMY. In this work the capac-
ity of rAv-TMY to modulate an allergic immune response to an unrelated antigen was investi-
gated. rAv-TMY was tested to interfere with the onset of an OVA induced airway inflamma-
tion. The results clearly indicate that rAv-TMY is able to ameliorate the symptoms of allergic 
airway inflammation.  
4.2.1 Tropomyosin as an allergen 
As initially described tropomyosin is a major food and aeroallergen of invertebrates 
[141,142]. The gut mucosal immune system is usually confronted with a myriad of bacterial 
and food derived antigens. In healthy individuals the immune system is primed to be tolerant 
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against harmless antigens but under certain conditions the induction of oral tolerance fails. 
Several factors leading to intolerance have been discussed. The route of uptake for instance 
seems to play an important role. There is incidence that the aberrant uptake of allergens via 
the skin or by inhalation (e.g. house dust mite tropomyosin) - bypassing the gut-mucosal bar-
rier - can lead to sensitization. Sensitized individuals subsequently react allergic to orally in-
gested antigens [143,144]. Other factors like genetic determinants, commensal gut flora, 
digestion of antigens during uptake and age are playing important roles in establishing atopic 
allergies. However, invertebrate tropomyosin exhibits strong IgE cross reactivity making a 
cross-sensitization likely. It is shown that sera of patients with allergy to indoor arthropods 
react also to shrimp tropomyosin indicating that a inhalation of tropomyosin of mites or 
cockroaches can lead to food allergy against shrimp tropomyosin [7,145,146]. Helminths also 
induce a strong IgE response among which tropomyosin is also recognized. The induction of 
reactive IgE by nematode tropomyosin [8,15,147] and their cross-reactivity to shrimp and 
house dust mite [8,148,149] has been demonstrated. The broad cross reactivity to tropomy-
osin gives rise to the question if helminth tropomyosin could induce allergic reactions to it-
self and/or tropomyosin of different organisms. Considering the fact that filarial nematodes 
express tropomyosin on their surface [8,9] and that the continuing turnover of microfilariae 
confronts the host with relevant amounts of tropomyosin makes this question even more 
appropriate. So far there are no studies linking helminth infections with the induction or en-
hancement to the clinical outcome of food allergies. However, for allergic airway disorders 
some correlations have been found. For Ascaris a correlation between the infection and an 
increased risk to develop asthma was demonstrated in cross-sectional study of children in 
China [95]. In contrast Wördemann et al. reported A. lumbricoides infections to be protective 
for atopic dermatitis but Enterobius vermicularis and hookworm infections to be risk factors 
to develop atopic dermatitis and/or allergic rhinoconjunctivitis [89]. On the other hand there 
is accumulating data showing an inverse correlation between helminth infections and the risk 
for allergic disorders. Van den Biggelaar and coworkers found a positive correlation between 
helminth infections and a negative skin prick test for house dust mite allergen in Gabonese 
school children. Interestingly a negative skin prick test was not correlated with lower total or 
specific IgE levels indicating that reduced IgE or induction of polyclonal IgE is not the main 
reason for reduced skin reactivity [80]. A further study of van den Biggelaar revealed a posi-
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tive correlation between helminth infections, increased IL-10 levels and lower prevalence of 
a positive skin reaction to house-dust mite [92]. These studies suggest that helminth infec-
tions do not prevent atopy but reduce the risk to develop an allergic reaction. This notion is 
supported by a study where allergic and non-allergic subjects of different socio-economic 
levels were compared. Individuals of high (HSEL) and medium socio-economic levels (MSEL) 
showed higher skin reactivity to common environmental allergens than their counterparts of 
low socio-economic levels (LESL). Lower skin reactivity correlated with high total IgE levels 
and a much higher worm burden [85]. Most studies were done with adults or older children 
leaving out an important time frame in which individuals first encounter enviromental anti-
gens and also helminths. Dagoye and colleagues addressed this question in a nested case-
control study supporting a negative correlation between helminth infections and wheezing in 
children between one and four years old [81]. However, there are further reports providing 
evidence for the beneficial capacities of helminth infections in regard to allergic inflamma-
tion [83,86,91,92,93]. Surveys regarding whole helminth infections of course do not exclude 
the allergenicity of a single parasite molecule. Helminths are shown to release several immu-
nomodulators inducing a regulatory phenotype that can counterbalance the allergenic fea-
tures of single molecules.  
Nevertheless, there are reasons arguing against a strong allergenicity of Av-TMY. First, As-
turias and colleagues showed that tropomyosin is probably not a major allergen as sera of 
Anisakis simplex patients were found to be non-reactive with native or recombinant A. sim-
plex tropomyosin [147]. Second, the prevalence of helminth infections in developing coun-
tries is very high whereas the incidents of food allergies is very low compared to western 
countries [143]. This negative correlation again argues against a strong allergenic or cross-
reactive property of helminth derived allergens, in that case tropomyosin. Third, the recogni-
tion of tropomyosin by IgE does not necessarily mean that tropomyosin is also allergic. As 
mentioned atopic individuals often found to be non-allergic. Furthermore for peanut aller-
gens it was shown that IgE antibodies of atopic patients with severe reactions recognize 
more peanut epitopes than those with mild or no symptoms [150,151] and stronger binding 
of antigen could account for an enhanced immune response. Hence, tropomyosin of worms 
might induce a more polyclonal IgE response which results in a reduced allergenicity. The 
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above discussed points show that the allergenicity of an allergen is dependent on many fac-
tors and that an IgE response is not necessarily followed by an allergic reaction.  
4.2.2 rAv-TMY alleviate OVA induced airway hyperresponsiveness  
To test the hypothesis that rAv-TMY exhibit immunomodulating capacities to bystander aller-
gens rAv-TMY was applied in preventative model of OVA induced airway inflammation. Ani-
mals were sensitized to OVA and during sensitization treated with rAv-TMY or the control 
protein rDHFR respectively. Airway inflammation was provoked by intranasal application of 
OVA. Changes in the inflammatory response between treated and untreated (sensitized only) 
animals were evaluated by measuring the cell influx into the airway lumen, antibody re-
sponse and mucus production. 
A hallmark of asthma is the increase in CD4+ T cells of the Th2 subtype combined with mas-
sive influx of eosinophils into the airways whereas in healthy individuals Th1 cells dominate 
[63]. In this study rAv-TMY drastically reduced the numbers of immigrating immune cells into 
the BALF. The reduction in lymphocytes goes along with a reduction in T helper cells thereby 
limiting the release of pro-inflammatory cytokines and the promotion of a Th2 bias (reviewed 
in [63,64,69]). The importance of mainly CD4+ T cells was demonstrated by Gavett and col-
leagues who showed that the depletion of CD4+ T cells in a murine in vivo model of asthma 
abrogated antigen induced AHR and airway eosinophilia [152]. It is of importance that eosi-
nophils, the main effector cells in allergic airway inflammation, were strongly reduced in the 
BAL [65,67]. As an important source of mediator and effector molecules such as IL-13, hista-
mines, leukotrienes (LT) and platelet-activating factor (PAF) reduced eosinophil numbers 
might lead to diminished mucus production [65]. Reduced eosinophil numbers were also 
seen in the lung interstitium by histological sections. Notably the size of cell infiltrations 
around the vessels and bronchioles did not differ between treated and untreated animals but 
the proportion of eosinophils compared to total cells within these cell conglomerates was 
substantially decreased.  
Another feature of asthma is a remarkable increase in allergen specific IgE antibodies [61]. 
Antigens bound to IgE effectively cross-link FcεRs on mast cell resulting in degranulation and 
tissue damage. As first line effector cells mast cells have an important role in induction and 
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maintenance of inflammation upon allergen exposure [153]. rAv-TMY significantly dimin-
ished the production of allergen specific IgE thereby limiting the activation of mast cells.  
As an outcome of reduced cell influx and lowered IgE levels symptoms of the allergic airway 
inflammation measured by mucus hyper secretion were reduced. The mucus production was, 
however, not completely absent. This indicates that rAv-TMY does not completely block the 
effector functions but rather mitigate symptoms.  
4.2.2.1 The role of IgG in rAv-TMY mediated immune modulation 
Helminth infections are known to induce a shift in the IgE/IgG4 ratio towards IgG4 in humans 
[49,139]. It was therefore of interest if rAv-TMY is able to induce such a shift. Indeed rAv-TMY 
induced a dramatic rise in rAv-TMY specific IgG1 (human IgG4) antibodies whereas OVA did 
not induce an IgG1 response at all. Increased IgG1 levels have at least two implications. First, 
IgG1 can compete for IgE epitopes on the antigen. This prevents cross-linking of FcεRs on 
mast cells resulting in a reduced degranulation frequency [70,154]. Second, IgG1 can cross-
link the FcγRIIb with FcεRI/FcγRIIb on mast cells what cause an inhibitory signal [70,155]. rAv-
TMY was also potent in stimulating the production of IgG2a and IgG2b two subclasses gener-
ally considered to occur under Th1 conditions [155]. If and to what extent this antibodies 
might contribute to the ameliorating effects of rAv-TMY stays elusive. They might somehow 
have a “diluting” effect by competing for receptor binding sites and epitopes. In humans it is 
well established that specific immune therapy leads to high antigen specific IgG1 (mouse 
IgG2a) titers but the role in desensitization are still unknown [70,156,157]. Wilson and co-
workers found an increase in allergen specific IgG2a antibodies in H. p. bakeri infected mice 
sensitized to OVA although not reaching statistical significance, arguing for a role of IgG2a in 
the abatement of allergy. [137]. 
4.2.2.2 Influence of rAv-TMY on cytokine expression 
To address the question about possible mechanisms and the involvement of mediators the 
local and systemic cytokine pattern was analyzed. Allergies are commonly associated with a 
Th2 dominated cytokine environment [63]. Analysis of the BALF revealed similar IL-4 and IL-
10 levels in all groups and a substantial reduced IL-5 expression in rAv-TMY treated vs. OVA 
only sensitized animals. Both, OVA and rAv-TMY were able to stimulate spleen cells to pro-
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duce the before mentioned cytokines with rAv-TMY being a little bit less effective to induce 
IL-4 expression. This constellation suggests a modified Th2 response which is characterized 
by an increased expression of IL-10 and IL-4 but reduced amounts of IL-5 [93,158]. The ex-
pression of IL-4 and the induction of IgE indicate that rAv-TMY features some characteristics 
of an allergen. On the other hand the induction of IL-10 adds a regulatory element. Intrigu-
ingly rAv-TMY was also able to induce IFN-γ production by spleen cells and reduce the effec-
tor cytokine IL-13 in the BALF. The possible roles of this cytokines will be discussed in the 
following part. 
IL-4 is a key cytokine in the induction of a Th2 response and is associated with allergies and 
helminth infections. IL-4 can be initially induced by antigen presentation to TCR in a MHC 
class II context. The activation of GATA-3 then leads to expression of IL-4 and IL-2. IL-4 itself 
acts as a positive feedback cytokine for Th2 differentiation. This process is counter regulated 
by IFN-γ [159]. It might be speculated that the induction of IFN-γ by rAv-TMY account for the 
diminished IL-4 production by spleen cells. However, spleen cells responded with production 
of IL-4 and IL-13 upon stimulation with OVA or rAv-TMY. Consistently, a class switch to IgE, 
reflected by high amounts of total IgE was found. In the airways rAv-TMY reduced the IL-13 
but not the IL-4 production compared to sensitized only animals. Importantly, IL-4 is also re-
sponsible for the down regulation of the high affinity IgE receptor FcεRI on mast cells 
[68,160]. Taken together this might imply that IL-4 on the one hand induces IgE on the sys-
temic level but on the other hand down regulates the respective receptor in the local envi-
ronment. Low expression levels of FcεRI would imply a desensitization of mast cells despite 
high levels of IgE. Consistent with this study protective effects against OVA induced airway 
inflammation were also reported for whole helminth infections. Protection was found even 
though a Th2 response against the parasite was mounted seen by unchanged or even in-
creased IL-4 levels in the BAL of infected animals [137,161]. Furthermore IL-4 recruits eosi-
nophils from the blood stream by inducing the expression of endothelial adhesion molecules, 
most prominently VCAM-1 [65,66]. Congruent with the unaltered IL-4 levels in the BALF of 
treated animals VCAM-1 was not changed in the airways seen by qPCR (data not shown). This 
indicates that rAv-TMY does not alter the trans-endothelial migration of eosinophils.  
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The recruitment and maturation of eosinophils is thought to be mainly managed by IL-5. 
Consistently with reduced IL-5 levels in the BALF and Sera (data not shown) the influx of 
eosinophils was significantly reduced in treated animals. Eosinophils derive from CD34+ lym-
phohemopoietic stem cells. They start to mature in response to IL-3 and GM-CSF but IL-5 is 
most important for proliferation, release from bone marrow, maturation and terminal differ-
entiation [67,162]. In addition IL-5 induces degranulation of eosinophils [67]. So far IL-5 is the 
main player in recruiting eosinophils but redundant mechanisms must exist. Flood-Page and 
colleagues found that treatment with the anti-IL-5 antibody mepolizumab only reduced air-
way eosinophil numbers by 50% and had no effects on the airway hyperreactivity. Interest-
ingly, staining for major basic protein revealed no differences between treated and placebo 
group [163]. This indicates that 50% of eosinophils can account for the same amount of re-
leased granule proteins as in untreated individuals. A stronger degranulation of the remain-
ing eosinophils might be due to a different/enhanced degranulation signal that compensates 
the lacking eosinophils. The absolute eosinophils numbers are therefore not the only factor 
contributing to inflammation. However, an impact of helminthes or their products on the 
local and systemic IL-5 production in allergic disease models have been described. Kitagaki 
and co-workers showed that H. p. bakeri infection reduced IL-5 secretion in the BALF and 
caused an intermediate response of splenocytes upon antigen or mitogen stimulation in an 
OVA induce asthma model [164]. The impact of an H. p. bakeri infection on the IL-5 concen-
tration in the BALF was confirmed by Wilson et al [137]. Reduced IL-5 levels in the BALF were 
also reported for treatment with the MIF homologue of A. simplex [60]. Moreover egg anti-
gen of Schistosoma japonicum potently inhibited IL-5 production measured in the BALF and 
sera of OVA sensitized mice [165]. In contrast, Wang and colleagues found a profound in-
crease in the IL-5 production by CD4+ T cells and a secretion into the BAL in mice infected 
with Strongyloides stercoralis [166]. In general helminth infections are associated with induc-
tion of IL-5 expression [167]. The differential expression of IL-5 in spleen and airways found in 
this study and by others [158,164] points towards a compartmentalization of the immune 
response induced by helminthes or their products. This might lead to a Th2 response on the 
systemic level but a modified Th2 response in the local tissue. The alteration of IL-5 and IL-4 
expression might also have an indirect impact on the IL-13 production, probably one of the 
main effector cytokines regulating mucus hyperplasia and AHR. IL-13 is mainly released by 
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Th2 T cells but also by mast cells, basophils and eosinophils. IL-13 induced STAT6 signaling 
can trigger the expression of a variety of mediators such as chemokines (eotaxin, MCP) and 
goblet cell inducing mediators (LT, TGF-α et al.) [168]. IL-13 was reduced by half in the BALF 
of rAv-TMY treated animals compared to sensitized only animals. This effect might be ex-
plained by the decreased influx of cells into the airways and the reduced activation status. 
Nonetheless, rDHFR had a similar effect indicating that this protein is not completely inert in 
this system. Reduced IL-13 secretion to the BALF together with ameliorated airway inflamma-
tion was also reported for treatments with the A. simplex MIF homologue and the A. suum 
PAS-1 protein [60,103]. In contrast, infections with male S. mansoni (precluding eggs) were 
reported to increase IL-13 secretion in the BALF and to induce an antigen specific IL-13 ex-
pression by spleen cells despite protecting animals from OVA induced airway inflammation 
[161]. In the present study spleen cells of rAv-TMY treated animals responded to OVA and 
rAv-TMY by expressing IL-13. Taken together rAv-TMY seems to differentially alter the IL-13 
expression locally and systemically. The observation that rAv-TMY changes the IgE / IgG1 ra-
tio and suppresses OVA specific IgE despite a systemic IL-4 and IL-13 production raises the 
questions which signal is responsible for this outcome. One candidate is IL-10. IL-10 is shown 
to potently trigger B cells to express IgG4 and suppress IgE [56,169,170,171]. This is in line 
with several findings showing that helminth infections induce IL-10 production together with 
mouse IgG1 [172] or human IgG4 [173] respectively. Moreover it was shown that specific 
immunotherapy has similar effects [157,169,174]. However, the suppressive function of IL-10 
is meanwhile extended to interference with eosinophil survival and cytokine release, the 
deactivation of mast cells and hampering antigen presentation by DCs (see also Fig. 23; re-
viewed in [55,175]). Arock and colleagues showed a reduced eosinophil survival by an IL-10 
dependent suppression of GM-CSF released by bone marrow-derived mast cells [176]. These 
findings were extended by Takanaski and co-workers showing a suppression of LPS induced 
autogenous production of GM-CSF leading to reduced survival of eosinophils in vitro [177]. 
IL-5 expression in T cells, however, seems to be also suppressed by IL-10 [178,179]. IL-5 and 
GM-CSF induce the expression of the anti-apoptotic gene Bcl-xL in eosinophil [180]. A sup-
pression of IL-5 and/or GM-CSF by IL-10 might therefore lead to increased apoptosis of eosi-
nophils. The anti-inflammatory effects of IL-10 in vitro are meanwhile confirmed by in vivo 
inflammation models. Tournoy et al. demonstrated suppressive effects of endogenous IL-10 
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on allergen induced airway inflammation. IL-10-/- mice developed stronger eosinophilia and 
had a higher baseline level of AHR compared to wild type mice [181]. Moreover Fu and co-
workers achieved reduced allergen responsiveness by intra-tracheal application of IL-10 ex-
pressing plasmids [182]. It is therefore of no surprise that helminth induced modulation is 
also mediated by IL-10. Kitagaki and colleagues showed that suppression of OVA induced 
airway inflammation by a H. p. bakeri infection was abrogated in IL-10 knock out mice [164]. 
In contrast Wilson and co-workers reported IL-10 independent mechanism in the same 
model. Applying an anti-IL-10 mAb did not influence the protective capacities of a H. p. bak-
eri infection and protection could be transferred by CD4+ cells from IL-10-/- mice [137]. Never-
theless, an important role of IL-10 mediating tolerance in OVA induce airway inflammation 
was also reported for infections with N. brasiliensis and male S. mansoni [161,183]. Further-
more IL-10 induced by Hymenolepis diminuta could ameliorate symptoms in a Th1 based 
colitis model [184]. In the same line Schnöller et al. showed the suppressive effects of single 
nematode derived molecule in a model of allergic airway inflammation and colitis. This proc-
ess was found to alter the antigen presentation by APCs rather than inducing regulatory T 
cells [102]. The multi suppressive effects of IL-10 suggest this cytokine to be a main player in 
the rAv-TMY induced modulation. From this study it remains unclear whether IL-10 might be 
only important as an initial trigger to induce the antibody shift and/or to interfere with the 
onset of inflammation or if it is needed on a constant level.  
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Fig. 23 Potential role of IL-10 in orchestrating a modified Th2 immune response. The early induction of IL-10 
by rAv-TMY might lead to a modified Th2 response that interferes with the onset and severity of airway inflam-
mation. IL-10 might suppress the onset of inflammation due to reduced IgE mediated degranulation and cyto-
kine release by mast cells in the airways. IL-10 thereby creates a local anti-inflammatory environment that feeds 
back also on dendritic cells and other APCs. The production of pro-inflammatory cytokines by DCs is inhibited 
by IL-10. By reducing the expression of MHC class II and co-stimulatory molecules on DCs IL-10 prevents or ab-
ates the subsequent induction of Th2 T cells in the draining lymph nodes. This results in a reduced inflammation 
in the late asthmatic reaction (LAR) upon allergen restimulation. In LAR the effector function of mast cells can 
be inhibited by a shift in the IgE / IgG1 ratio towards blocking IgG1 antibodies. In addition the survival, cytokine 
production and degranulation of eosinophils in the airways can be diminished. Overall these effects can lead to 
an attenuated inflammatory response and reduced symptoms. Modified from Havrylowicz & O’Garra, 2005. DC: 
dendritic cell, B: B cell, APC: antigen presenting cell, MHC class II: major histocompatibility complex class II, FcR: 
fragment crystallizable (region) receptor 
 
4.2.2.3 rAv-TMY alters eosinophil migration by repressing chemokine expression 
As stated above IL-5 might not be the only chemoattractant and activation signal for eosino-
phils. Furthermore, IL-13 is shown to potently induce chemokines such as eotaxin and mono-
cyte chemoattractant protein (MCP) and reduced IL-13 levels might alter the chemokine ex-
pression. To clarify a possible impact of rAv-TMY treatment in the regulation of the 
chemokine production the expression of several cytokines in the airways was analyzed. As 
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mentioned before the VCAM-1 expression was not altered leaving the trans-endothelial mi-
gration of eosinophils intact. However, the allocation of eosinophils within the interstitium 
was different in treated animal, suggesting an altered homing signal. One putative candidate 
is CCL12 (MCP-5) that showed lowered mRNA levels in the lung tissue. CCL12 is described to 
rather alter the trafficking of eosinophils through the lung interstitium than to recruit eosi-
nophils from the blood stream [185]. MCP-5 is expressed at early time points of the allergic 
response what might explain the minor difference between OVA and rAv-TMY groups in this 
study [186].  
Two other chemokines - eotaxin-1 (CCL11) and eotaxin-2 (CCL24) - showed a decrease ex-
pression in the lung of rAv-TMY treated animals. Both target CCR3 and are able to exclusively 
guide eosinophils along the gradient to its destination [67,187]. Analysis of the CCR3 expres-
sion in the airways conducted conflicting results in either being up- or down regulated upon 
rAv-TMY treatment (data not shown). This might be due to the fact that only little parts of 
the lung were used for RNA isolation which might contain unequal numbers of eosinophils. 
Little is known about the regulatory pathways concerning eotaxin. It was demonstrated that 
IL-4, IL-13, TNF-α and histamine induce eotaxin expression alone or in a synergistical way in 
human fibroblasts or airway smooth muscle cells [188,189,190,191]. However, eotaxin induc-
ing effects of IL-4, IL-13 and TNF-α were not seen in endothelial or epithelial cells [192] con-
flicting with the notion that epithelial cells are one of the major sources of eotaxin beside 
mast cells. Therefore the way how rAv-TMY could trigger the down regulation of eotaxin 
stays elusive. Nevertheless, the suppression of eotaxin seems to be a common feature of 
helminth infections resulting in reduced eosinophilia in the respective inflammation models. 
Infections with H. p. bakeri were shown to reduce eotaxin levels and eosinophilia in the BALF 
of BALB/c mice sensitized to OVA and in C57BL/6 mice sensitized to the house dust mite anti-
gen Der p 1 [137]. Similar to H. p. bakeri N. brasiliensis abates eotaxin expression and eosi-
nophilia in the lung. Interestingly, in natural infections without sensitization to OVA N. brasil-
iensis induced strong eosinophilia in the lung. The cell influx followed a kinetic with 
eosinophilia peaking at two weeks post infection and returned to baseline levels as soon as 
eight weeks post infection. This kinetic was also seen in OVA sensitized animals showing that 
the immune response modulated by a N. brasiliensis infection seems to override the re-
sponse to the allergen OVA [193]. However, single helminth derived molecules were also re-
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ported to impact eotaxin expression. The protein PAS-1 of A. suum was shown to reduce eo-
taxin expression and eosinophilia in the BAL of OVA sensitized mice. Intriguingly this effect 
was abrogated in IFN-γ and IL-10 but not in IL-12 knockout mice indicating an important role 
of these mediators in the regulation of eotaxin [103]. It might be that the induction of IL-10 
and IFN-γ expression by rAv-TMY in spleen cells is also mediating the suppression of eotaxin. 
Conversly, treatment with excretory/secretory products of N. brasiliensis (NES) protected 
mice from OVA induced airway inflammation in an IL-10 and IFN-γ independent fashion 
[183]. A possible explanation might be the difference between a single molecule and a mix-
ture of several potentially modulating proteins. The latter one might influence the immune 
response through different and possibly IL-10/IFN-γ independent ways. Furthermore it was 
shown that metalloproteases released by the hookworm N. americanus cleaves eotaxin in 
vitro and in vivo [194]. The matrix metalloproteases (MMP) 9 and 2 are described to be im-
portant in the regulation of cell recruitment probably by a degrading chemokines. However, 
the effects of matrix metalloproteases are conversely discussed in being beneficial or detri-
mental in the course of allergic airway inflammation. MMP9 knockout mice showed in-
creased cell recruitment into the lungs and increased levels of CCL11 and CCL22 in an OVA 
induced airway inflammation. This indicates a critical role of MMP9 in the regulation of eosi-
nophil migration [195]. Similar results were obtained in an Aspergillus fumigatus allergen 
induced model of airway inflammation. Using MMP9-/- and MMP9/MMP2 double knockout 
mice the authors proposed independent and overlapping contributions of this two proteases 
to cell egression from the lung by regulating the transepithelial chemokine gradient [196]. 
However, opposite results were obtained in a different study using also MMP9 knockout 
mice. Upon OVA challenge significantly less mononuclear cells infiltrated the lung and AHR 
was reduced compared to wild type mice [197]. In mycobacteria infections the expression of 
MMP9 in macrophages is induced in a TLR-2 dependent manner [198]. As rAv-TMY induces 
the expression of TLR-2 on macrophages it is reasonable that rAv-TMY might induce metallo-
proteases in a TLR-2 associated way thereby influencing the chemokine mediated cell influx 
and/or egression. 
Intriguingly, eotaxin-2 has been shown to cooperate with IL-5 in the lung to orchestrate eosi-
nophilia, mucus hyperproduction and AHR in an OVA-induced model of airway inflammation. 
Yang and colleagues also demonstrated that the local presence of both IL-5 and eotaxin-2 in 
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the airways is crucial to induce pulmonary eosinophilia and AHR [199]. This model fits well to 
the findings that rAv-TMY treatment reduce IL-5 production in the BALF and sera (data not 
shown), eotaxin-2 expression in the lung tissue and subsequently the IL-13 secretion into the 
BALF. However, reduced expression of eotaxin can have further implications. In the last years 
a phenomenon called “piecemeal degranulation” (PMD) got into the focus of research [200]. 
Basophils, mast cells and eosinophils are able to differentially secrete their products. Eotaxin 
was shown to induce the differential secretion of IL-4 by eosinophils [201]. If this process can 
for example also trigger the exclusive secretion of IL-13 by either mast cells or eosinophils is 
unknown but this mechanism adds a further explanation for micro environmental regulation 
of inflammation. 
4.2.2.4 rAv-TMY immune modulation does not involve regulatory T cells 
Helminths have been shown to induce regulatory T cells as an important cell type in helminth 
mediated immune modulation and in regulation of allergic airway diseases 
[137,165,202,203]. Furthermore, rAv-TMY induced IL-10 expression what might suggest the 
involvement of regulatory T cells. Treg cells are known to impair the ability of DCs to activate 
effector T cells by cell-cell interaction, IL-10 and TGF-ß production and the expression of 
CTLA4 soon after migration to the lymph nodes. The re-migrating DCs then lack the ability to 
activate T cells in the airways [47]. Therefore the proportion of CD4+ cells expressing the Treg 
marker CD25 and the activation marker CD103 in the PBLNs was investigated. No differences 
in the proportion of Treg cells within the PBLNs primed to migrate to the airways were found 
in all groups compared to the naïve animals suggesting that Treg cells do not play an impor-
tant role in rAv-TMY induced immune modulation. The slight increase in Treg cells in sensi-
tized and treated animals might be a response to the ongoing inflammation in both groups. 
However, as CD25 can be also upregulated on activated conventional CD4+ T cells and PBLN 
cells were not analyzed for Foxp3 expression, an impact of rAv-TMY on the induction of Treg 
cells cannot be completely excluded. 
4.2.2.5 rAv-TMY influence IgA expression 
In allergic airway diseases the antigen is first encountered by Immunoglobulin A at the muco-
sal surface. IgA was long time thought to have only a “neutralizing” function by excluding the 
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multitude of dietary, environmental and microbial antigens that bombard the mucosal sur-
face. Meanwhile it has become clear that IgA and its receptor FcαRI regulate various re-
sponses such as degranulation, phagocytosis and cytokine release by granulocytes, mono-
cytes and macrophages in humans [204]. It was therefore of interest to analyze if rAv-TMY 
would alter the IgA expression and secretion into the BALF respectively. Total IgA secretion 
into the BALF was significantly reduced in rAv-TMY treated animals compared to OVA alone 
treated whereas the sera levels of IgA were the same in all groups (data not shown). The role 
of serum IgA antibodies is mostly unknown but it was proposed that the role of circulating 
IgA is to keep the immune system under tight steady state control [205]. Therefore, one 
would expect serum IgA expression to be unchanged in mucosal associated diseases such as 
asthma. Concerning secretory IgA (sIgA) there exist conflicting data. sIgA is the most abun-
dant immunoglobulin in mucosal secretions with a variety of five receptors expressed for 
example on eosinophils [204]. Schwarze and colleagues found an improvement of allergic 
symptoms (reduced AHR, eosinophil infiltration, IL-4 & IL-5 and restored IFN-γ) in a ragweed 
model of allergic airway disease when they administered specific ragweed (Amb a I) IgA in 
the airways i.e. high levels of sIgA correlated with abatement of symptoms [206]. In contrast 
it was reported that in an OVA induced asthma model AHR, eosinphilic infiltration and Th2 
cytokine production was accompanied with a strong increase in total IgA in the BALF as well 
as in the supernatant of ex vivo mononuclear cells of the lung [207]. Along the same line a 
more recent report showed that IgA induce degranulation of eosinophils more potently than 
IgE indicating an underestimated role of IgA antibodies in eosinophil activation [208]. Nota-
bly IgA was also found to have regulatory functions. Woerly et al. could induce IL-10 secre-
tion from human blood eosinophils when sIgA immune complexes were present and IL-2/IFN-
γ secretion by targeting CD28 on eosinophils. Combining the IgA and CD28 stimulus abro-
gated the secretion of all three cytokines [209]. Furthermore it was shown that monomeric 
targeting of the FcαRI ameliorated allergic response in an in vivo asthma model and reduced 
IgE/FcεRI mediated histamine release by RBL cells in vitro. In contrast, cross linking of FcαRI 
led to activation and histamine release [209]. The dual function of the FcαRI was confirmed 
by Kanamaru et. al showing that monomeric targeting of FcαRI trigger a “low-density” signal 
leading to cell desensitization whereas multimerization gives a “high-density” signal and acti-
vates cells [205]. These interesting findings implicate that low concentration of multivariant 
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sIgA induce desensitization and that high concentrations of specific sIgA might form immune 
complexes, induce activation and degranulation of eosinophils respectively. Nonetheless, 
most studies were done with human blood eosinophils which might substantially differ from 
activated airway eosinophils in regard to receptor expression. This might lead to the follow-
ing assumption concerning rAv-TMY treatment in this study: 
1. IgA levels reduced by rAv-TMY treatment lead to reduced degranulation of eosinophils 
2. Low concentration of rAv-TMY and OVA specific (multivariant) sIgA result in a desensitiza-
tion signal in eosinophils 
These conclusions, however, have a weakness as mouse eosinophils do not express FcαRI, 
the receptor that is thought to account for most effects in humans. Decot and colleagues 
found only transferrin receptor 1 (TfR-1) expressed on the surface of mouse eosinophils and 
the Fcα/µ receptor at the transcriptional level [210]. So far not much is known about the 
specific interplay between TfR and IgA and the regulatory potential. Arguments for a regula-
tory role of TfR or unknown IgA receptors in mice, similar to the role as FcαRI in humans, are 
provided by the studies of Schwarze and Schneider how both used a mouse model [206,207]. 
Furthermore, the existence of putative IgA receptors in mice leading to IgA mediated signal-
ing are proposed [204,210,211,212]. 
4.2.3 Model of rAv-TMY immune modulation 
The above discussed effects of rAv-TMY suggest the induction of a modified Th2 response by 
rAv-TMY [53,93,158]. Such a modified Th2 response is characterized by differential expres-
sion of IgE and IgG4, IL-4 / IL-10 production, down regulated IL-5 responses and subsequently 
reduced involvement of eosinophils. A modified Th2 response was also reported to be pro-
tective against OVA induced airway inflammation in schistosoma infected mice. This was a 
specifically localized pulmonary effect with an “intact” systemic OVA-specific response (IL-4, 
IL-5, IL-13 response by spleen, sera IgE, IgG). Fallon and Mangan suggested a compartmen-
talization of immunity allowing a modified Th2 response in the lung with a concurrent “nor-
mal” systemic response [158]. The treatment with rAv-TMY might also create compartmen-
talization of the immune reaction between lung and systemic effects.  
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The combined expression of IL-4 and IL-10 as well as the modified antibody response involves 
several implications on mast cell effector functions and T-cell priming (extracted from human 
and mouse studies):  
3. IL-4 and IL-10 have competitive functions regarding IgE expression. IL-4 induce IgE ex-
pression whereas IL-10 diminishes it and favor’s a switch to IgG4 [213] 
4. Both cytokines inhibit the FcεRI expression on mast cells an basophils [154,214] 
5. As the increase in FcεRI expression depends on high IgE levels, an environment leading to 
low IgE supports FcεRI suppression [154,214] 
6. Reduced IgE mediated antigen uptake can lead to lowered antigen presentation by APCs 
(B-cells, DC, macrophages, monocytes) thereby decreasing sensitivity for the antigen by 
100- to 1000-fold. Subsequently the production of IL-4, IL-5, recruitment of eosinophils 
and allergen specific T-cell response are impaired [169]. 
7. High levels of IgG4 leads to cross linking of the inhibitory FcγRIIB resulting in reduced de-
granulation and activation of mast cells, although FcγRIIB is a low affinity receptor and 
actual effects are questionable [70] 
8. Cross linking of FcεRI and FcγRIIB by IgG4 antibodies inactivates mast cells [70] 
9. Reduced IgA levels lead to reduced degranulation of eosinophils [215] 
10. Low concentration of multivariant IgA results in a desensitization signal in eosinophils 
[205] 
Hence, it becomes evident that the combination of low IgE and high IgG1 level and IL-10 ex-
pression attenuates the allergic reaction as seen in animals treated with rAv-TMY. Fig. 24 de-
picts a hypothetical model of rAv-TMY mediated immune modulation.  
The observed effects of treatment with rAv-TMY are similar to what is seen in specific immu-
notherapy (SIT). Specific allergen immunotherapy with allergen extracts is the only causal 
treatment with long term effects even after treatment discontinuation [169]. The precise 
mechanisms underlying SIT are not fully understood yet. But what is observed in humans is 
the induction of immunoglobulin G production, predominantly IgG4 and IgG1, a blunting of 
seasonal IgE increase and increased IL-10 and TGF-β production by regulatory T cells. Fur-
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thermore the eosinophil, mast cell and basophil infiltration is reduced and a decrease in their 
activation threshold was found [156,157]. There are several mechanisms proposed for the 
immune modulation by SIT.  
First, it was demonstrated that SIT-induced IgG responses inhibited basophil and mast cell 
degranulation either by direct inhibition of allergen-IgE interaction or by cross linking of 
FcγRIIB and FcεRI. Second, blocking antibodies induced by SIT inhibited the IgE-FcεR medi-
ated antigen presentation. These effects lowered the dose needed to activate allergen spe-
cific T cells by 100- to 1000 fold. The decline in mediator release by effector cells and T cell 
activation might allow the immune system to recover a more regulatory or Th1 based im-
mune response. The modulation seen by rAv-TMY treatment, however, seems to mimic ef-
fects seen by SIT in a much faster progression. The faster progression is probably due to the 
immediate induction of IL-10 leading to fast isotype switch in the antibody response. 
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Fig. 24 Potential role of Fc receptors and antibodies in the modulation of allergic airway inflammation by rAv-
TMY.  Allergic airway inflammations are characterized by a Th2 dominated environment with high levels of IL-
4 and IL-13. The combined action of this cytokines leads to class switch towards IgE producing B cells. High le-
vels of IgE lead to stabilization of FcεRI on mast cells and subsequently to cross linking of FcεRI by antigen spe-
cific IgE, resulting in degranulation. High levels of IgA might also contribute to increased IL-4 and IL-5 secretion 
by eosinophils upon cross-linking of IgA receptors.  Modulation might take place through the combined ac-
tion of IL-4 and IL-10 induced by rAv-TMY which down regulates FcεRI expression on mast cells and basophils. In 
addition IL-10 induces the production of blocking IgG1 antibodies. As a result degranulation of mast cells is 
inhibited by a reduced cross-linking of FcεRI, action of the inhibitory FcγRIIb and antigen dilution by IgG1. As 
mast cells are crucial for the initiation of inflammation, this mechanism might prevent or diminish antigen in-
duced inflammation. Furthermore, reduced amounts of IgA with different specificities (OVA & rAv-TMY) can 
lead to a “low-density” signal in eosinophils upon which IL-10 production is increased and IL-5 decreased. IL-10 
might also downregulate IgA receptors on eosinophils. As most studies concerning the role of IgA and its recep-
tors are done in the human system, receptors and mechanisms might differ in the murine system.  Moreover 
rAv-TMY might interfere with the activation of antigen presenting cells. Professional APCs express the high affin-
ity receptor FcεRI and B cells the low-affinity receptor CD23 through which IgE bound antigen is processed for 
presentation to T cells. IgE mediated antigen presentation can increase sensitivity for the antigen by 100-1000 
fold. This process is, however, blocked under conditions with low IgE levels and reduced expression of 
FcεRI/CD23. It was also shown that TLR-2 on dendritic cells can inhibit the FcεRI expression. B: B cell, APC: anti-
gen presenting cell, TLR-2: toll-like receptor 2, TfR: Transfering receptor, Th2: T-helper cell 2, MHC class II: Major 
Histocompatibility Complex II, FcR: fragment crystallizable (region) receptor, Ig: immunoglobulin 
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4.2.4 rAv-TMY promotes TLR-2 expression on macrophages and their efflux from the 
peritoneum 
Increased TLR-2 expression was found to correlate with decreased susceptibility to asthma 
[216]. Furthermore, helminth derived products are shown to modulate immunity via TLRs 
[101,217,218,219,220]. In addition preliminary experiments with rAv-TMY using a TLR-2 re-
porter cell line revealed that rAv-TMY signals via TLR-2. This findings lead to the speculation 
that rAv-TMY might also utilize TLR-2 for modulation. To investigate this question rAv-TMY or 
a control protein were injected into the peritoneum and PEC were isolated 18 hours later for 
FACS analysis. The analysis revealed a significant efflux of macrophages (F4/80highGr-1-) from 
the peritoneum. Intriguingly the emigrating macrophage population showed a much higher 
TLR-2 expression than those of PBS or DHFR treated ones. This hints towards a direct influ-
ence of rAv-TMY on macrophages and presumably DCs via TLR-2. A similar effect is described 
for Lyso-PS, a schistosomal lysophosphatidylserine (Lyso-PS), acting on dendritic cells via TLR-
2 and thereby influencing Tregs to produce IL-10. Interestingly, anti-TLR-2 antibody treat-
ment during stimulation of DC with schistosomal PS revealed that the subsequently primed 
T-cells lose their ability to produce IL-10 but keep their “Th2-phenotype” indicated by a high 
IL-4 to IFN-γ ratio [218]. Furthermore it was shown that soluble egg antigen of schistosomes 
suppresses DC activation (MHC class II, CD80, CD86) and IL-12 production in a TLR-2 depend-
ent manner [221]. Other helminth derived products such as ES-62 or dsRNA of schistosom 
eggs act on TLR-4 and TLR-3 respectively indicating that helminth PAMP recognition by TLRs 
is a common feature [101,219,220]. TLR-2 is the most promiscuous representative of all TLRs 
concerning its ligands amongst others lipoteichoic acid of gram-positive bacteria, GPI anchor 
of Trypanosoma cruzi and Lipophosphoglycan of Leishmania major. TLR-2 collaborates with 
TLR-1 /-6 and various other non-TLR PRRs thereby increasing its ligand repertoire and the 
effector function [222]. The preferential outcome of TLR induction is a Th1 response. De-
pending on the cell and the engagement of co-receptors TLR stimulation might also lead to a 
Th2, regulatory or Th17 response [223]. In contrast, TLR-2 stimulation on dendritic cells, 
macrophages and monocytes preferentially promotes Th2 or regulatory T cell differentiation 
and induces IL-10 production via the PI-3K-Akt signaling pathway [222]. Recently it has been 
demonstrated that targeting TLR-2 on human mast cells reduced FcεRI expression and de-
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granulation of ex vivo pulmonary mast cells. These effects were specific for TLR-2 and FcεRI 
but varied between different TLR-2 ligands [224]. Furthermore, stimulation of human mast 
cells via TLR-2 resulted in IL-10 release and IL-10 reduced the expression of FcεRI on mouse 
mast cells [214,225]. Hence, a TLR-2 mediated suppression of FcεRI expression on mast cells 
might be a further explanation how rAv-TMY account for the reduced allergic responses al-
though it might be questionable if the molecule injected into the peritoneum actually 
reaches the airways. The mechanisms how rAv-TMY might act on TLR-2, if co-receptors are 
involved, which APC types are targeted and if and how APCs might trigger IL-10 production 
by T-cells have to be investigated. 
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5 Summary / Outlook 
This study illustrates the limits of RNAi as method for functional gene studies in the parasitic 
nematode H. p. bakeri and, taking the database analysis into account, most probably also in 
other parasitic strongylids. The development of an invasive delivery method for dsRNA/siRNA 
and/or sid-1/sid-2 transgenic parasites might overcome these limits. 
Using an in vivo model of allergic airway inflammation it could be demonstrated that the 
muscle protein tropomyosin of A. viteae clearly modifies the immune response to an unre-
lated allergen. Taken together rAv-TMY seems to desensitize the immune system for aeroal-
lergens. This is most likely due to a combined effect of reduced allergenicity of rAv-TMY and 
the induction of IL-10 leading to a modified Th2 response. However, treatment with rAv-TMY 
rather ameliorates then abrogates the symptoms of asthma and there are several questions 
still open. Does a long term treatment with rAv-TMY would increase the observed effects? 
Does rAv-TMY lead to the same outcome in an invertebrate tropomyosin induced inflamma-
tion model? How are local and systemic effects linked? What are the target cells and the sig-
naling pathway leading to the IL-10 production? Nevertheless, despite the many open ques-
tions rAv-TMY might be an attractive desensitization therapeutic. In SIT recombinant 
antigens which have reduced IgE binding capacities or allergoids lacking IgE binding sides but 
keep their T cell responsiveness are currently under investigation [157]. Helminth derived 
molecules might reflect this kind of reagents in a natural manner. Furthermore, the compari-
son of allergenic, non-allergenic and modulatory tropomyosin might put some light on the 
nature of allergens and their molecular patterns. 
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6 Materials and methods: 
6.1 Animal models 
6.1.1 Animals used for experiments 
For asthma experiments female BALB/c mice (Ol1a-Hsd) were purchased from Harlan 
Winkelmann (Borchen, Germany) or used from the own breeding facility, (HU Berlin) respec-
tively. For asthma experiments mice were kept in individually ventilated cages, for other ex-
periments animals were housed in standard cages. All mice were housed and handled follow-
ing national guidelines and as approved by the animal ethics committee. 
6.1.2 … in RNAi experiments 
6.1.2.1 Feeding of C. elegans 
Feeding of the nematodes was performed as described before [41]. The worms were allowed 
to feed for 3 days on recombinant bacteria. Subsequently three hermaphrodites were trans-
ferred each to an individual well. Each hermaphrodite was allowed to lay eggs for 24 h and 
removed afterwards. The resulting progeny was analyzed with regard to phenotypical 
changes and the total number of worms was determined after three days.  
6.1.3 … in Asthma experiments 
6.1.3.1 Model of murine airway inflammation 
Female BALB/c mice (Harlan-Winkelmann, Bachem, Germany) were sensitized twice (day 0 
and day 14) intraperitoneally with 20 µg OVA (grade VI, Sigma-Aldrich, Steinheim, Germany) 
emulsified in 2 mg of aluminum hydroxide (Imject ®Alum, Pierce, Rockford, USA). On days 28 
and 29, mice were challenged intranasally with 50 µg OVA (25µl per nostril). Within the 
model 20 µg recombinant A. viteae tropomyosin diluted in a total volume of 200 µl low-
endotoxin PBS or the same amount of control protein DHFR was injected intraperitoneally 
four times in weekly intervals during the sensitization (see also p. 33 Fig. 11). Naive control 
animals were treated with PBS in aluminum hydroxide intraperitoneally and challenged with 
PBS intranasally.  
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Two days after challenge mice were sacrificed and the following analyses were carried out:  
• lavage of the lung to assess BALF and cell numbers and types pointing to inflammation  
• removal of spleen to perform cell culture  
• removal of peribronchial lymph nodes (PBLN) to perform FACS analysis  
• cryoconservation of parts of the lung to perform Real-Time-PCR  
• preparation of lungs for histological analysis (formalin)  
• assessment of blood to monitor antibody production  
 
6.1.3.2 Bronchoalveolar lavage (BAL)  
Animals were sacrificed by cervical dislocation and lungs were lavaged twice using a tracheal 
drain tube with 0.8 ml of cold PBS/EDTA (proteinase inhibitor tablets, completeTM Mini, 
Roche). The volumes of the lavages was measured by weighing and after centrifugation (10 
min, 2.000 rpm, 4 °C) supernatants of the first lavages were stored at -20 °C for cytokine 
analyses. The cell pellets of both lavages were resuspended in a total of 1 ml PBS, cell num-
bers were counted and 100 µl of the cell suspensions was used to prepare cytospin slides. 
Cytospin slides were stained with DiffQuick (Dade Behring AG) and bronchoalveolar lavage 
(BAL) cells were differentiated by morphological criteria (count of 200 cells under light mi-
croscopy), as previously described by Blumchen [226].  
6.1.3.3 Histological analysis of lung  
Lungs were collected in 3.5 % formalin to be embedded in paraffin later on. Slices of 5 µm 
were cut and afterwards stained with HE (hematoxilin/eotaxin) to monitor cells types and 
infiltration in lung tissue or stained with PAS to visualize mucus production in bronchioles 
[227]. Slides were analyzed regarding bronchioles and their surrounding by light microscopy 
with a 40- and 400- fold magnification. 
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6.2 Molecular biology and biochemistry 
6.2.1 … in RNAi experiments 
6.2.1.1 Feeding - Plasmid preparation and transformation 
For the RNAi experiments an 855bp cDNA fragment of H. p. bakeri encoding tropomyosin 
(Hp-tmy) was cloned into pGEM-T Easy vector (Promega, Mannheim, Germany). The se-
quence was analyzed with regard to its GC content to find areas with an increased chance to 
produce 21 nt fragments by DICER [228]. The full length sequence (designated as cHp-tmy) 
and a 165bp part of the 5’ end (designated as Hp-tmy-1) of tropomyosin were subcloned into 
the L4440 vector and expressed in the Escherichia coli strain HT115 (DE3) as described else-
where [20,229,230]. As control we used the pLT61.1 vector (addgene, Fire Lab C. elegans 
Vector Kit, USA) carrying the Ce-unc-22 gene encoding for twitchin. Ce-unc-22 dsRNA results 
in a clear phenotype in C. elegans (positive control) [20,231] and no phenotype in H. p. bak-
eri. As negative control the non-coding malE part of the maltose binding protein (MBP) was 
used. 
6.2.1.2 Soaking - Target design, plasmid preparation and in vitro transcription  
Soaking is described to work most efficiently with sequences of 100 bp to 500 bp [16]. There-
fore, Hp-tmy-1 (bp 1-165) and Hp-tmy-2 (bp 582-855) were cloned into the L4440 vector be-
tween two flanking T7 promoters. The target sequence was amplified with T7 primers and 
the resulting fragment gel purified. For in vitro transcription of dsRNA the MEGAScript RNAi 
Kit (Ambion, Austin, USA) was used according to the manufacturer’s instructions with the 
following modifications. A single step PCR was used for amplification at 37°C for 4h. After 
DNA/RNA digestion the dsRNA was purified by ethanol precipitation and dissolved in RNAse 
free water. Purity and integrity was regularly checked on a standard agarose gel. Concentra-
tion of dsRNA was measured at 260 nm using a NanoDrop1100 (NanoDrop Technologies, 
Wilmington, USA) photometer and stored at -20°C until usage. 
To analyze its uptake Hp-tmy-1 dsRNA was labeled with the Cy3 dye using the Silencer® 
siRNA Labeling Kit (Ambion, Austin, USA) according to manufacturer’s instructions.  
6.2.1.3 RNA extraction from H. p. bakeri 
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All RNA extractions were performed with the RNAeasy Mini Kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions with the following changes. Adult worms were 
transferred into Qiagen RNAlater and stored at -80°C. After thawing the supernatant was 
discharged and 50 µl RLT-ß-mercaptoethanol lysis buffer (RLT, Qiagen, Hilden, Germany; ß-
ME Sigma-Aldrich, Munich, Germany) was added. The worms were squelched and frozen in 
liquid nitrogen, 150 µl RLT-ß-ME was added and eventually remaining worms were ground 
again. 400 µl RLT-ß-ME was used to wash the tube and the suspension was homogenized us-
ing QIAshredder columns (Qiagen, Hilden, Germany). The remaining steps were performed 
following the manufacturer’s instructions including a 15 min DNA digestion and RNA concen-
tration determined by photometry on a NanoDrop1100. 
6.2.1.4 cDNA synthesis  
RNA was reverse transcribed using the TaqMan® Reverse Transcription Reagent (Applied Bio-
systems, Darmstadt, Germany). The same amount of total RNA for each approach was ap-
plied to adjusted reaction volumes. Buffer and cycling conditions were used according to the 
manufacturer’s instructions with oligo hexamers as primers.  
6.2.1.5 qPCR TaqMan® relative gene expression assay for RNAi experiments 
The sequence of Hp-tmy cDNA was aligned against the respective C. elegans genomic se-
quence to determine the putative exon-exon borders to prevent amplification of genomic 
DNA. Primers and probes (Tab. 2) were designed with the PrimerExpress® software (Applied 
Biosystems, Darmstadt, Germany) spanning a putative exon-exon region.  
Tab. 2 Primers and probes used in the qPCR TagMan® assay 
Target Gene Accession No. Primer / Probe Name Sequence (5’ – 3’) 
Hp-18s AY542283 f: HP_18S-T2F GCACGCGCGCTACAAT 
  r: HP_18S-T2R AACGGTTTACCAATGCCTTTCG 
  p: HP_18S-T2M2 FAM-CCAGCTGATTCTTCC-NFQ 
Hp-tmy EU131541 f: HP_TROPO-T3F GCCAACTGGAGGAGAAAGACAAG 
  r: HP_TROPO-T3R GGTTCAGGGCAGCTACCT 
  p: HP_TROPO-T3M2 FAM-TCAGCCTCCTGGACTTT-NFQ 
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To prevent amplification of Hp-tmy template DNA the primers were located between Hp-
tmy-1 and Hp-tmy-2 (p. 24, Fig. 5). 18s RNA of H. p. bakeri served as endogenous control. 
Amplification efficiency of the primers was tested by a standard curve assay. Linear regres-
sion analysis showed similar slopes for all tested primers (Tab. 3).  
Tab. 3 Slope and coefficient of determination (R²) of the standard curve assay; A slope of -3,32 represents a 
PCR reaction of 100% efficiency. 
Primer Slope R² 
Hp-tmy -3,1392 0,9944 
Hp-18s -3,0686 0,9919 
 
The Real-Time PCR was performed on an AB7000 (Applied Biosystems, Darmstadt, Germany) 
using the conditions as presented in Tab. 4. Values were normalized to Hp-18s RNA as en-
dogenous control. Relative gene expression was calculated using the –∆∆Ct formula [232]. 
Tab. 4 Reaction and cycling conditions used for a 20 µl qPCR TaqMan® approach 
Gene Target Primer Probe cDNA 1:10 Cycling Conditions 
 [nM] [nM] [µl]  
Hp-18s 900 250 1 10 min @ 94°C; 40x  (15 sec @ 95°C, 60 sec @ 60°C) 
Hp-tmy 900 250 6 10 min @ 94°C; 40x  (15 sec @ 95°C, 60 sec @ 60°C) 
 
6.2.2 … in Asthma experiments 
6.2.2.1 Plasmid preparation and transformation 
For Asthma experiments Av-TMY was cloned into a pQE30 expression vector (Qiagen, Hilden, 
Germany) and expressed in E. coli XL-1 blue as described elsewhere [15]. 
6.2.2.2 RNA extraction from lung tissue 
For RNA preparation tissues were frozen in liquid nitrogen and then ground with ice-cold 
mortar and pistil. The powdered material was then treated according to manufacturer’s in-
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structions of RNeasy Mini Kit (Qiagen, Hilden, Germany) followed by digestion of DNA using 
the RNase-free DNase-Set (Qiagen) according to the manufacturer’s instructions.  
6.2.2.3 cDNA synthesis  
RNA was reverse transcribed using the TaqMan® Reverse Transcription Reagent (Applied Bio-
systems, Darmstadt, Germany). The same amount of total RNA for each approach was ap-
plied to adjusted reaction volumes. Buffer and cycling conditions were used according to the 
manufacturer’s instructions with oligo hexamers as primers.  
6.2.2.4 SYBR green relative gene expression assay for asthma experiments 
The sequence for the Primer were obtained from Primer Bank (see Tab. 5) and validated in a 
melting curve assay for specificity [233,234]. Glycerinaldehyd-3-phosphat-Dehydrogenase 
(GAPDH), ß-actin, peptidylprolyl isomerase A (PPIA) and hypoxanthine guanine phosphoribo-
syl transferase (HPRT) served as endogenous control. The Real-Time PCR was performed on 
an AB7000 (Applied Biosystems, Darmstadt, Germany) using FastStart universal SYBR green 
master mix (Roche 04913850001) and the conditions as presented in Tab. 6. Values were 
normalized to endogenous control RNA and relative gene expression was calculated using 
StatMiner software.  
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Tab. 5 Primers used in the qPCR SYBR green assay. Primers were obtained from the Primer Bank database 
(http://pga.mgh.harvard.edu/primerbank/index.html); f: forward, r: reverse 
Target Gene PrimerBank ID Primer name Sequence (5’ – 3’) 
CCL2 6755430a1 f: CCL2_fw TTAAAAACCTGGATCGGAACCAA 
  r: CCL2_rv GCATTAGCTTCAGATTTACGGGT 
CCL5 7305461a1 f: CCL5_fw GCTGCTTTGCCTACCTCTCC 
  r: CCL5_rv TCGAGTGACAAACACGACTGC 
CCL11 6755418a1 f: CCL11_fw GAATCACCAACAACAGATGCAC 
  r: CCL11_rv ATCCTGGACCCACTTCTTCTT 
CCL12 6755420a1 f: CCL12_fw ATTTCCACACTTCTATGCCTCCT 
  r: CCL12_rv ATCCAGTATGGTCCTGAAGATCA 
CCL24 9625035a1 f: CCL24_fw ATTCTGTGACCATCCCCTCAT 
  r: CCL24_rv TGTATGTGCCTCTGAACCCAC 
CCR3 31542354a1 f: CCR_fw TCAACTTGGCAATTTCTGACCT 
  r: CCR_rv CAGCATGGACGATAGCCAGG 
VCAM-1 31981430a1 f: VCAM1_fw AGTTGGGGATTCGGTTGTTCT 
  r: VCAM1_rv CCCCTCATTCCTTACCACCC 
GAPDH 6679937a1 f: GAPDH_fw AGGTCGGTGTGAACGGATTTG 
  r: GAPDH_rv TGTAGACCATGTAGTTGAGGTCA 
PPIA 6679439a1 f: PPIA_fw GAGCTGTTTGCAGACAAAGTTC 
  r: PPIA_rw CCCTGGCACATGAATCCTGG 
HPRT 7305155a1 f: HPRT_fw TCAGTCAACGGGGGACATAAA 
  r: HPRT_rw GGGGCTGTACTGCTTAACCAG 
ß-actin 6671509a1 f: bAct_fw GGCTGTATTCCCCTCCATCG 
  r: bAct_rw CCAGTTGGTAACAATGCCATGT 
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Tab. 6 Reaction and cycling conditions used for a 20 µl qPCR SYBR green approach 
Primer PCR-Mix cDNA 1:10 Cycling Conditions 
[nM] [µl] [ng / µl]  
300 10 1,25 
10 min @ 95°C 
40x (15 sec @ 95°C, 60 sec @ 60°C) 
1x (15 sec @ 95°C, 60 sec @ 60°C, 15 sec @ 95°C) 
 
6.2.2.5 Purification of recombinant Av-TMY 
A pQE30::Av-TMY clone was incubated overnight at 37°C in 30 ml LB medium containing 100 
µg/ml Ampilicin and 20 µg/ml tetracyclin. 10 ml of overnight culture was used to start large 
scale cultures (300-500 ml), in which expression of the protein was induced by addition of 1 
mM IPTG isopropyl β-D-thiogalactoside for 3 h when cultures reached an optical density 
(OD600) of 0.6. After centrifugation (4 °C, 6,000 rpm, 15 min) pellets were resuspended in 
20-30 ml lysis buffer A1 containing lysozym and incubated 30 min on ice while constantly 
shaking. Lysates were sonificated (2x 80 sec., 20 %) and centrifuged again (4 °C, 12,000 rpm, 
15 min) to get protein containing supernatants. Supernatant was loaded on HiTrap FF col-
umns of a FPLC (fast performance liquid chromatography). rAv-TMY was bound to the col-
umns via the attached His-tag followed by a washing step with buffer A2 and a fractionized 
elution with buffer B. Fractions were loaded on a SDS-PAGE to determine expression, purity 
and size of purified proteins. Fractions with highest protein concentration and purity were 
pooled and used for endotoxin removal. After endotoxin removal flow through was dialyzed 
against low endotoxin PBS using centrifuge concentration units to an approximate concentra-
tion of 200 µg/ml. Actual concentrations was measured in a bicinchoninic acid test and rAv-
TMY stored at -20°C. 
6.2.2.6 Endotoxin removal by EndoTrap  
To remove endotoxin contaminations from rAv-TMY purifications, EndoTrap blue columns 
were used according to the manufacturer´s instructions (Profos, Regensburg, Germany) with 
following modifications: columns were equilibrated with buffer B and both buffer B and Pro-
tein solution were substituted with 100 µm Ca2+. 
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For rDHFR decontamination EndoTrap red columns were used according to the manufac-
turer´s instructions (Profos, Regensburg, Germany). 
6.2.2.7 Limulus amoebocyte test (endotoxin measurement)  
Final endotoxin concentrations were detected by limulus amoebocyte lysate (LAL) test (Cam-
brex, Bio Sciences, Walkersville, USA) according to manufacturer’s instructions.  
6.2.2.8 Quantification of protein  
Protein concentrations were measured with the bicinchoninic acid test using BCA protein 
assay kit (Pierce) according to manufacturer’s instructions (Pierce, USA). 
6.2.2.9 SDS-PAGE (sodium-dodecyl-sulfate polyacrylamid gel electrophoresis) and 
coomassie staining  
SDS-PAGE was used to determine expression, purity and size of induced proteins. SDS-PAGE 
separates proteins according to their size. Differences in polarization are mainly eradicated 
by denaturation with β-mercaptoethanol and heat and binding of anionic SDS to the proteins 
in constant ratios. According to the expected size of the wanted protein separation gels of 10-
14 % polyacrylamid were used, always with a 6 % stacking gel. Gels were run at 120V/400mA. 
To visualize proteins gels were stained 30 min at 60 °C with coomassie staining solution. Un-
bound coomassie was washed away with de-staining solution. 
6.3 Parasitological methods 
6.3.1 Parasite maintenance 
6.3.1.1 Life cycle of H. p. bakeri 
H. p. bakeri was maintained by serial passage in BALB/c mice. Mice were infected with 
approx. 200 L3 using a feeding tube. Infective larvae were obtained from fecal cultures. Feces 
were collected from infected animals, washed in distilled water and plated in Petri dishes on 
humid blotting paper for 7 days. On day 7, L3 were washed from the plate and kept in dis-
tilled water at 4 °C after extensive washing. L3 were used for infection up to 8 weeks after 
fecal culture.  
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6.3.1.2 Life cycle of A. viteae 
The life cycle of A. viteae was maintained essentially as described by Lucius and Textor [235]. 
Briefly, the infective L3 stages of A. viteae were obtained from infected Ornithodoros mou-
bata ticks and used to infect Meriones unguiculatus subcutaneously with app. 70 L3. The L3s 
develop to the L4 and subsequently to the adult male and female stages. The female worms 
release microfilariae into the peripheral blood. The peripheral blood of infected Meriones 
was used to infect ticks where the microfilariae develop to the L2 and subsequently to the 
infective L3 stages. 
6.3.2 … in RNAi experiments 
6.3.2.1 E. coli HT115 as food source 
To prevent an excessive grow of bacteria H. p. bakeri larvae are usually fed on the uracil 
auxotroph E. coli strain OP50 preventing an overgrow of the larvae. To test the E. coli strain 
HT115 as food source 3400 H. p. bakeri eggs were seeded on HT115 or OP50 lawns on NGM 
agar plates [236]. The proportion of larvae that had developed to L3 was calculated in rela-
tion to the applied egg number after six days. 
6.3.2.2 Preparation of eggs and feeding of H. p. bakeri 
Feces from H. p. bakeri infected BALB/c mice were collected for a time period of 8-12 h. H. p. 
bakeri eggs were obtained by flotation with saturated sodium chloride solution [237]. Bacte-
ria and fungi were removed by treatment with bleaching solution (1,67 M NaOH + 3,34% 
NaOCl, added to a final concentration of 30% (v/v) for 10 min) and eggs were washed twice 
with M9 buffer (22 mM KH2PO4, 42 mM Na2HPO4, 17 mM NaCl, 1 mM MgSO4) supple-
mented with tetracyclin (20 µg/ml), ampicillin (100 µg/ml) and counted using a MacMaster 
chamber [237].  
Bacterial lawns of recombinant HT115 on NGM agar containing tetracyclin (20 µg/ml), am-
picillin (100 µg/ml) and 1 mM IPTG were prepared in 12 well plates and allowed to express 
dsRNA for 12 h at RT. Subsequently, each well was seeded with 1000 H. p. bakeri eggs and 
left at RT for 7 days to finally determine the proportion of eggs that had developed to viable 
L3.  
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6.3.2.3 Feeding on bacteria expressing the green fluorescent protein (gfp) 
Recombinant E. coli BL21 containing the pET28b-EGFP plasmid were grown in LB medium 
with kanamycin (100 µg/ml) and seeded on NGM plates containing kanamycin (100 µg/ml) 
and 1mM IPTG. After 12 h of induction eggs of C. elegans or H. p. bakeri were transferred to 
the plates. Hatched L1 larvae were examined under a fluorescent invert microscope for up-
take of bacteria.  
6.3.2.4 Electroporation of adult worms and larvae 
For electroporation a BTX ECM830 square wave electroporator with a 2 mm cuvette and a 
commercial electroporation buffer (Ambion, Austin, USA) as well as a trehalose buffer (272 
mM trehalose, 7 mM KH2PO4 pH 6, 1 mM MgSO4) [37] was used for transfection with Cy3-
siRNA (Ambion, Austin, USA). Conditions for voltage and pulse time are presented in Tab. 7. 
Tab. 7 Electroporation conditions 
 No. Voltage [V] Time [ms] Buffer 
La
rv
ae
 500 
500 
100-1000 
500 
0,1 / 1 / 5 /10 / 15 / 20 
3,5 / 5,4 / 8,9 / 10 / 30 / 50 
Trehalose 
Ambion / Trehalose 
A
du
lt
s 
10-40 100-3000 0,1 / 1 / 5 /10 / 20 /30 / 40 Trehalose 
 
6.3.2.5 Soaking of H. p. bakeri adult worms 
Adult worms were recovered from the small intestine of H. p. bakeri-infected BALB/c mice 
and washed several times in 0,9% NaCl solution followed by an incubation in RPMI 1640 
(Gibco, Invitrogen, Karlsruhe, Germany), supplemented with 1% penicillin/streptomycin at 
37°C for 1-2 h. Subsequently, 20 adult worms each were kept in 260 µl RPMI 1640 (w/o FCS) 
supplemented with 1% penicillin/streptomycin, 8 U RNaseOUT™ recombinant ribonuclease 
inhibitor (Invitrogen, Karlsruhe, Germany) and 0,5 µM of Hp-tmy-1 Cy3-dsRNA and incubated 
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at 37°C under 5% CO2 for 18 h. Worms were washed with prewarmed RPMI 1640 and ana-
lyzed for dsRNA uptake using a fluorescent microscope.  
The knock down experiments were carried out as stated above with six groups each consist-
ing of two males and three females kept in 50 µl RPMI supplemented with 2 µM of the re-
spective dsRNA. After 24 h or 6 days of dsRNA soaking, the adult worms were examined with 
regard to morphological changes by light microscopy. The tropomyosin mRNA level was de-
termined by qPCR. Alternatively adults were soaked in dsRNA as described and subsequently 
kept for further 48 h in dsRNA free medium  
6.4 Immunological methods 
6.4.1 Enzyme-linked immunosorbent assay (ELISA) 
6.4.1.1 Serum levels of IgE (total and OVA-IgE), OVA-IgG1, OVA-IgG2a  
Total IgE levels were measured by sandwich ELISA using anti-IgE antibody as catcher, 3% BSA 
in PBS to block unspecific binding, dilutions of sera (1:10, 1:100, 1:1000, 1:10000 in blocking 
buffer) containing induced antibodies and anti-IgE antibody coupled to Biotin as detection 
antibody. HRP (horseradish peroxidase) labeled streptavidin was applied in a 1:10000 dilution 
to detect Biotin-labeled antibodies and binding was visualized by application of the HRP-
substrate TMB. After stopping the reaction with 1M H2SO4 plates where measured at 450/630 
nm in a plate reader. IgE-standard solution was analyzed in accordance to samples to calcu-
late IgE amounts.  
OVA-specific antibodies where measured in an analogical. After application of diluted sam-
ples 3 µg/ml biotinylated ovalbumin was used to detect exclusively OVA-specific IgE antibod-
ies. To calculate amounts, purchasable IgG1-standards or IgE-and IgG2a standard sera were 
used, respectively. OVA-specific IgE and IgG2a are therefore calculated as lab units (LU) and 
not in µg [238]. 
6.4.1.2 Serum levels of IgG subclasses specific for OVA or rAv-TMY  
200 ng/well of the referring protein was coated in carbonate buffer overnight and plates 
were blocked with 3 % BSA / TBS. Sera were applied in 1:50 dilution (in 1 % BSA / TBS) and 
antibody subclasses were detected by use of subclass-specific AP (alkaline phosphatase)-
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labeled detection antibodies and AP-substrate (0,1 mg/ml p-Nitrophenylphosphat, 1 mM 
MgCl2 in carbonate buffer). Reaction was abrogated with EDTA and measured at 405 / 630 
nm in ELISA reader. 
6.4.1.3 Serum / BALF levels of total IgA  
96 well plates were coated with 50 µl anti-IgA antibody catcher in carbonate buffer over 
night at 4°C. Wells were blocked with 200 µl of 3% BSA in TBS for 30 min at RT. 50 µl of stan-
dard, sera or BALF per well was incubated for 2h at RT followed by an incubation with 50 µl 
of AP labeled detection antibody for 1h at RT. 50 µl substrate (0,1 mg/ml p-
Nitrophenylphosphat, 1 mM MgCl2 in carbonate buffer) were added and incubated for 30 
min at 37°C. Reaction was abrogated with EDTA and measured at 405 / 630 nm in ELISA 
reader. 
6.4.1.4 Cytokine detection  
IL-4, IL-5 and IL-10 measurements were performed using OptEIA ELISA kits according to 
manufacturer’s instructions, but using 50 µl of samples and standards / well. IL-13 was ana-
lyzed by R&D IL-13 ELISA kit also according to manufacturer’s instructions, but using 50 µl of 
samples and standards / well.  
6.4.2 Cytometric Bead Array 
In several experiments  cytokine bead arrays were performed to analyze IL-4, IL-5, IL-6, IL-10, 
IL-12p40, IL-13, IFN-γ, TNF-α simultaneously according to manufacturer’s instructions (BD™ 
Cytometric Bead Array Flex Set) but using 10 µl of capture beads and detection reagent. 
Briefly, Sera ore BALF of mice were incubated with cytokine specific antibodies bound to 
beads with a distinct fluorescent intensity for one hour in 96 well plates. PE labeled cytokine 
specific antibodies were added and incubated for another hour. Plates were centrifuged and 
supernatant discarded. After one washing step beads were resuspended in wash buffer and 
analyzed by flow cytometry. Bead-populations were discriminated by the FL3 and FL4 chan-
nels and cytokine concentration calculated by the mean fluorescent intensity of the PE chan-
nel according to the standard curve.  
6.4.3 Flow cytometric analysis  
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Surface staining of lymphocytes using mAb was performed in PBS / 0.2 % BSA / 5 mM EDTA / 
pH 7,4 on ice and in the dark for 15 min. Cell suspensions (1x106 total cells) were washed in 
PBS/BSA and stained with αCD4, αCD25 and αCD103 to detected Treg cells.  
Macrophages in peritoneal exudate cells (PEC) were stained for αCD11b-FITC, αF4/80-Cy5 and 
αGr-1-biotin/SA-PE-Cy7.  
TLR-2 expression on macrophages was measured by labeling PECs with αF4/80-Cy5 and αTLR-
2-PE. Unspecific binding of the mAbs was blocked by the addition of αFcγRII/III (20 µg/ml). 
Cytometric analysis was performed using FACS Calibur or LSRII and FlowJo software. 
6.5 Cell culture techniques 
6.5.1 Preparation of splenocytes and peribronchial lymph node cells (PBLNC)  
PBLN and spleen were isolated aseptically from euthanized mice. Organs were dissociated 
bypassing them through a steel mesh in PBS pH 7.4 containing 0.2% BSA to obtain single cell 
suspensions. Erythrocytes were removed by resuspension of washed cells in erythrocyte lysis 
buffer for 5 min on ice. After washing, cells were adjusted to desired concentrations in cRPMI 
for culture or PBS/BSA for surface stainings and flow cytometry analysis. In the asthma 
model spleen mononuclear cells were isolated by density gradient centrifugation (Lym-
pholyte-M, Cedarlane Laboratories, Hornby, Ontario, Canada). Cells were cultured with a 
density of 1 x 106 cells/well in RPMI 1640 (10 % FCS, Pen/strep, L-Glu and fungi) for 96 hours 
in the presence of 10 µg/ml OVA, 10 µg/ml rAv-TMY, 10 µg/ml DHFR or 2,5 µg/ml concana-
valin A (ConA). Cell culture supernatants were stored at -20 °C until performance of cytokine 
ELISA. 
6.5.2 Peritoneal lavage and preparation of peritoneal exudate cells (PEC)  
To obtain PEC the peritoneal cavity of sacrificed mice was washed 4 to 5 times with 2 ml ice-
cold RPMI. Cells were centrifuged and lysis of erythrocytes was performed. After counting 
cells were centrifuged and resuspended in PBS / 0,2% BSA for FACS staining. 
6.6 Statistics 
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Statistics were performed using analysis of variance (ANOVA) to prove significant differences 
between more than two groups. ANOVA was followed by a post hoc test to prove significant 
differences between single groups (Dunn’s or Mann-Whitney-Test). Post hoc test was only 
performed if ANOVA resulted in p ≤ 0.05. Differences between individual groups were tested 
to be significant for p < 0.05, p < 0.01 or p < 0.001. Statistics were performed using GraphPad 
Prism version 5.01 for Windows (GraphPad Software, San Diego California USA, 
www.graphpad.com).  
 
6.7 Database analysis 
The sequences of 18 C. elegans proteins involved in RNAi were used to search for orthologs 
in different databases using a BLAST. Sequences were aligned against the EST database of H. 
contortus (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/h_contortus, assembled con-
tigs 27 / 01 / 06, TBLASTN, low complexity filter), the whole genome shotgun (WGS) data-
base of B. malayi (http://tigrblast.tigr.org/er-blast/index.cgi?project=bma1; tblastn, default 
settings) and the genome assembly database version 3 (GAV3) of Schistosoma mansoni 
(http://www.sanger.ac.uk/cgi-bin/blast/submitblast/s_mansoni, TBLASTN, low complexity 
filter). Sequences with a p-value below e-5 were considered as homologous. Homologous 
sequences were subsequently used to search for conserved domains in the conserved do-
main database (CDD) available on NCBI 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi, threshold 0.01, low complexity fil-
ter) that matches known domains of the blasted proteins. 
 
 
 
 
6.8 Material 
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6.8.1 Laboratory equipment  
Flow cytometer: LSRII BD Biosystems, San Jose, CA  
ELISA-reader Dynatech, Denkendorf, Germany BioTek, Vermont, USA  
Ultrasound-disintegrator Heinemann, Schw. Gmünd, Germany  
Real-time PCR system 7300 Applied Biosystems, Foster City, CA  
Cytocentrifuge (cytospin) ThermoShandon, Frankfurt, Germany 
Square wave electroporator BTX ECM830, BTX, Holliston, USA 
FPLC ÄKTA (UPC-900, P-920, Frac 900), Amersham Pharmacin Biotech, Uppsa-
la, Sweden 
6.8.2 Buffers and media  
Bleaching solution 1,67  M NaOH 
3,34%  NaOCl 
Added to final concentration of 30% v/v 
 
M9 buffer 22 mM KH2PO4 
42 mM Na2HPO4 
17 mM NaCl 
1 mM MgSO4 
 
Electroporation buffer Ambion, Austin, USA 
 
Trehalose buffer 272 mM trehalose 
7 mM KH2PO4 (pH 6)  
1 mM Mg SO4 
 
Coomassie 20% EtOH 
10% acetic acid 
2 tabl. PhastGel BlueR (Amersham Pharmacia Biotech, Uppsala, Sweden) 
Add to 1 l dest. Water 
 
De-staining buffer 20% EtOH 
10% acetic acid 
 
FACS staining buffer 0.2 % BSA in PBS 
 
FACS fixation buffer 0.2 % BSA 
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2 % paraformaldehyde  
in PBS 
 
Erythrocyte lysis buffer 0.01 M KHCO3
  
0.155 M NH4Cl  
0.1 mM EDTA  
pH 7.5 
 
Cell culture medium (cRPMI) RPMI-1640 5- 
10 % FCS  
20 mM L-glutamine  
100 U/ml penicillin  
100 μg/ml streptomycin  
all from Biochrom, Berlin, Germany 
 
Electroporation buffer Ambion, Austin, USA 
6.8.3 Protein purification buffers  
 
Lysis buffer A 300  mM NaCl  
50  mM NaH2PO4  
20  mM Imidazol  
pH 7,4 
 
Wash buffer A2 300  mM NaCl  
50  mM NaH2PO4  
30  mM Imidazol  
pH 8,0 
 
Elution buffer B 50  mM NaH2PO4 
300 mM NaCl 
250 mM Imidazol  
pH 8,0 
 
BAL-solution 10 ml PBS (Dulbecco's w/o)  
1 tabl. complete mini protease inhibitor (Roche) 
6.8.4 Chemicals and biologicals  
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Recombinant RNAse inhibitor RNAseOUT, Invitrogen, Karlsruhe, Germany 
RNA stabilization reagent RNAlater, Qiagen, Hilden, Germany  
RLT-ß-mercaptoethanol lysis buffer RLT, Qiagen, Hilden, Germany;  
ß-ME Sigma-Aldrich, Munich, Germany 
BSA, fraction V AppliChem, Darmstadt, Germany  
Proteinase inhibitor cocktail Roche, Mannheim, Germany  
Paraformaldehyde Sigma, München, Germany  
6.8.5 Commercial Kits 
pGEM-T Easy vector kit Promega, Mannheim, Germany 
C. elegans vector kit Addgene, Fire Lab, USA 
Silencer siRNA labeling kit Ambion, Austin, USA 
MEGAScript RNAi kit Ambion, Austin, USA 
OptEIA ELISA kits BD Biosciences, Heidelberg, Germany  
IL-13 ELISA-set R&D Systems, Minneapolis, MN  
BCA kit Pierce, USA  
TaqMan primer and probes Applied Biosystems, Darmstadt, Germany  
TaqMan cDNA synthesis kit Applied Biosystems, Germany  
TaqMan PCR master mix Applied Biosystems, Germany  
RNeasy Mini kit Qiagen, Hilden, Germany  
QIAshredder spin columns Qiagen, Hilden, Germany  
LAL QCL-1000 Cambrex, USA  
Cytokine bead array flex sets BD Biosciences, Heidelberg, Germany  
EndoTrap system blue Profos, Regensburg, Germany  
6.8.6 Software 
FlowJo (Tree Star, Inc., Ashland, USA) 
BD FACSDiva (BD Biosciences, Heidelberg, Germany)  
FCAP Array Software (Applied Biosystems, Darmstadt, Germany) 
Prism (GraphPad Software, San Diego California USA, www.graphpad.com) 
PrimerExpress (Applied Biosystems, Darmstadt, Germany) 
StatMiner (Integromics) 
 
 
 
6.8.7 Antibodies and secondary reagents 
6.8.7.1 FACS reagents 
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Specificity fluorochrome clone Purchased from 
αCD4 FITC RM4-5 BD Biosciences 
αCD25 PE PC61 BD Biosciences 
αCD103  (biotin) M290 BD Biosciences 
αF4/80  Cy5 F4/80 DRFZ* 
αCD11b FITC M1/70 BD Biosciences 
α Gr-1 Biotin  DRFZ* 
αTLR-2 PE 6C2 eBiosience 
αFcγR  2.4G2 DRFZ* 
    
Secondary reagents    
SA-PE-Cy7 PE-Cy7  BD Biosciences 
    
* mAb was a kind gift of the German Arthritis Research Centre. 
 
 
6.8.7.2 Antibody detection 
Immunoglobulin Capture ab Standard Detection ab 
total IgE 
αIgE 10µg/ml 
PC284 The binding site 
IgE 250ng/ml 
557079 Pharmingen 
αIgE-Bio 2,5µg/ml 
553414 Pharmingen 
OVA-IgE 
αIgE 2µg/ml 
553413 Pharmingen 
OVA standard serum #67 
1:64 
OVA-Bio 3µg/ml 
OVA-IgG1 
αIgG1 2µg/ml 
553445 Pharmingen 
OVA-spec. IgG1 340ng/ml 
A6075 Sigma 
OVA-Bio 3µg/ml 
OVA-IgG2a 
αIgG2a 2µg/ml 
553387 Pharmingen 
OVA standard serum #67 
1:64 
OVA-Bio 3µg/ml 
total IgA 
αIgA 10µg/ml 
104001 Southern Biotech 
mouse IgA isotype control 
1250-19,5 ng/ml 
eBioscience 14-4762-85 
αIgA-AP 1:3000 
104004 Southern Biotech 
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7 Abbreviations 
A.D. Atopic dermatitis  
Ab Antibody  
Ag Antigen 
AHR airway hyperresponsiveness 
AP Alkaline phosphatase 
APC Antigen presenting cell  
APS Ammoniumperoxydisulfat 
Av Acanthocheilonema viteae 
Av17 Acanthocheilonema viteae 17kDa immunomodulator (cystatin)  
BAC bacterial artificial chromosome 
BAL bronchoalveolar lavage  
BALF bronchoalveolar lavage fluid  
BCIP 5-brom-4-chlor-3-indolylphosphat 
Bio biotin 
Bm Brugia malayi 
BSA bovine serum albumin  
CCL C-type chemokine ligand 
CCR C-type chemokine receptors 
CDD conserved domain database 
COPD chronic obstructive pulmonary disease 
CTLA-4 cytotoxic T-lymphocyte antigen 4 
Cy3 Cyanine 3 (~550 nm excitation, ~570 nm emission) 
Cy5 Cyanine 5 (~650 nm excitation, ~670 nm emission) 
DAPI 4`,6-diamidino-2-phenylindol 
DC dendritic cell 
DHFR dihydrofolat reductase  
DMF dimethylformamid 
DMSO dimethylsulfoxid 
dsRNA double stranded RNA 
e.c. epicutanous 
E/S excretory/secretory 
EAE experimental autoimmune encephalomyelitis 
EAR early asthmatic response 
Ec Escherichia coli 
ECP extra-cellular matrix protein 
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EDTA ethylenediaminetetraacetic acid 
ES-62 excretory-secretory product (ES-62) of Acanthocheilonema viteae 
EST expressed sequence tag 
EU endotoxin unit 
FACS fluorescence activated cell sorter 
Fc fragment crystallizable (region)  
FcR fragment crystallizable (region) receptor 
FCS fetal calf serum 
FITC fluorescein isothiocyanate 
Foxp3 forkhead box transcription factor p3 
FSC forward scatter 
Gal galactosidase 
GAV3 genome assembly version 3 
GFP green fluorescent protein 
GITR glucocorticoid-induced TNF-receptor-related protein 
GM-CSF granulocyte-macrophage colony stimulating factor 
HDM house dust mite 
HELICc Helicase conserved C-terminal domain 
Hp Heligmosomoides polygyrus bakeri 
i.n. intranasal 
IFN interferon 
Ig immune globuline 
IL interleukin 
IL-10R interleukin-10 receptor 
ILN inguinal lymph node 
ILNC inguinal lymph node cell 
IPTG isopropyl-thio-b-D-galactopyranosid 
kan kanamycin 
KO knock out 
L3, L4 larvel stage 3, larvel stage 4 
LAR late asthmatic response 
LB Luria Bertani 
LPS lipopolysaccharides 
LT leukotriene 
LU lab unit 
mAb monoclonal antibody 
M∅ macrophage 
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MBP major basic protein 
mf microfilariae 
MHC major histocompatibility complex 
MIF macrophage-migration inhibiton factor  
min minute 
ml milliliter 
MLN mesenteric lymph node 
MLNC mesenteric lymph node cell 
MLV multilamellar vesicle 
MMP matrix metallopeptidase 
mRNA messanger RNA 
NBT nitro blue tetrazolium 
NC nitrocellulose 
ng nanogram 
NGM nematode growth medium 
NK natural killer cell 
NKT-cells natural killer T-cells 
NO nitric oxide  
Ov17 Onchocerca volvulus 17kDa immunomodulator (cystatin)  
OVA ovalbumin 
PAGE polyacrylamide gel electrophoresis 
PAMP Pathogen associated molecular pattern 
PAR protease activated receptors 
PAS 200-kDa protein component of Ascaris suum 
PAZ Piwi Argonaut and Zwille domain 
PBLN peribronchial lymph node 
PBLNC peribronchial lymph node cell 
PE phycoerythrin 
PEC peritoneal excudate cells 
Penh pause enhanced 
PGE prostaglandin 
PHA phytohaemagglutinin 
Piwi P-element induced wimpy testis 
PRR pattern recognition receptor 
PSTG post-transcriptional gene silincing 
RANTES acronym for Regulated on Activation, Normal T Expressed and Secreted 
RdRP RNA dependent RNA polymerase 
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RISC RNA induced silencing complex 
RNAi RNA interference 
RNase ribonuclease 
RT room temperature 
SA streptavidin 
SCF stem cell factor 
SDS sodium dodecylsulfate 
SID systemic RNAi deficient 
siRNA small interfering RNA 
SIT allergen-specific immunotherapy 
SOCS suppressor of cytokine signaling 
Taq Thermus aquaticus 
TGF transforming growth factor 
TGH TGF-ß homologue of Brugia malayi 
Th1 T helper cell 1 
Th17 T helper cell 17 
Th2 T helper cell 2  
TLR toll-like receptor 
TM tropomyosin 
TNF tumor necrosis factor 
Tr1 Type 1 regulatory (Tr1) cells, also known as inducible Treg cells 
Treg regulatory T cell 
TRIS 2-amino-2-hydroxymethyl-1,3-propandiol 
TSLP thymic stromal lymphopoietin 
VEGF vascular endothelial growth factor 
WGS whole genome shotgun 
X-Gal 5-brom-4-chlor-3-indolyl-b-D-galacto-pyranosid 
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